AUSTRALIAN CAPITAL TERRITORY

Poisons and Narcotic Drugs (Amendment) Ordinance 1988
No. 96 of 1988
I, THE GOVERNOR-GENERAL of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Ordinance under the Seat of Government (Administration) Act 1910. 
Dated 15 December 1988
	N. M. STEPHEN
	Governor-General
By His Excellency’s Command,
CLYDE HOLDING
Minister of State for the Arts 
and Territories

An Ordinance to amend the Poisons and Narcotic Drugs Ordinance 1978
Short title
1.  This Ordinance may be cited as the Poisons and Narcotic Drugs (Amendment) Ordinance 1988.1
Commencement
2.  This Ordinance commences on such date as is fixed by the Minister by notice in the Gazette.
Principal Ordinance
3.  In this Ordinance, “Principal Ordinance” means the Poisons and Narcotic Drugs Ordinance 1978.2
Substances to which Division applies 
4.  Section 27B of the Principal Ordinance is amended by adding at the end the following paragraphs:
	“;	(f)  follicle stimulating hormone;
		(g)  luteinising hormone;
		(h)  thalidomide.”.
Grant of authorisation
5.  Section 27E of the Principal Ordinance is amended—
	(a)	by omitting from paragraph (1) (a) “or cyclofenil” and substituting “, cyclofenil, follicle stimulating hormone or luteinising hormone”;
	(b)	by omitting from paragraph (1) (b) “and”; and
	(c)	by adding at the end of subsection (1) the following word and paragraph:
	“; and (d)	in the case of an application that relates to thalidomide—the applicant is a specialist physician with no less than 5 years’ experience in the treatment of erythema nodosum leprosum.”.
Substitution—Schedules
6.  Schedules 1 to 8, inclusive, and Schedule 12, to the Principal Ordinance are repealed and the following schedules respectively substituted:
	SCHEDULE 1	Section 3
Aconite (root of Aconitum napellus)
Antimony compounds, except—
	(a)	when included in Schedule 4; or
	(b)	antimony chloride in polishes
Atropine, except when included in Schedule 2 or 4
Belladonna, except when included in Schedule 2
Bromine, excluding its salts and derivatives
Brucine, except when used in concentrations of 0.02% or less for the denaturation of alcohol
Comfrey (Symphytum spp) for human internal use, being—
	(a)	any preparation; or
	(b)	any part of the dried plant
Coniine
Cotarnine
Croton Oil
Cyanides—see Hydrocyanic Acid
Homatropine, except when included in Schedule 2
Hydrocyanic Acid and Cyanides for therapeutic use, except when included in Schedule 2
Hyoscine, except when included in Schedule 2 or 4
Hyoscyamine, except when included in Schedule 2
Hyoscyamus, except when included in Schedule 2
Lobelia, except—
	(a)	when included in Schedule 2; or
	(b)	in preparations for smoking or burning
Lobeline, except—
	(a)	when included in Schedule 2; or
	(b)	in preparations for smoking or burning
Mercuric Chloride, except when included in Schedule 2 or 7
Mercuric Iodide, except when included in Schedule 2 or 6
Mercuric Nitrate, except when included in Schedule 2
Mercuric Potassium Iodide, except when included in Schedule 2
Mercuric Thiocyanate, except when included in Schedule 6
Mercury organic compounds, except—
	(a)	when included in Schedule 2, 4 or 6;
	(b)	ethoxyethylmercuric chloride and ethylmercuric chloride in Schedule 7; or
	(c)	in preparations containing 0.01% or less of mercury as a preservative
Nux Vomica
Phosphorus, Yellow (excluding its salts and derivatives), except when included in Schedule 6
Savin, oil of
Stramonium, except—
	(a)	when included in Schedule 2; or
	(b)	in preparations for smoking or burning
Tansy, oil of
Veratrum, except when included in Schedule 4

	SCHEDULE 2	Section 3
Acetic Acid (excluding its salts and derivatives) in preparations containing more than 80% of acetic acid, for therapeutic use
Aloxiprin
Ammoniated Mercury
Antazoline in eye drops
Aspirin, except—
	(a)	when included in Schedule 4;
	(b)	in tablets or capsules each containing 325 mg or less of aspirin as the only therapeutically active constituent, other than an effervescent buffering system, when—
(i)	the pack is labelled—
	“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR LONG PERIODS”; or
	“CAUTION—THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED. PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL”;
(ii)	packed in blister or strip packaging or in containers with a child-resistant closure; and
(iii)	in a primary pack containing not more than 25 such tablets or capsules; or
	(c)	in individually wrapped powders or sachets of granules each containing 650 mg or less of aspirin as the only therapeutically active constituent, other than an effervescent buffer, when—
(i)	the pack is labelled—
	“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR LONG PERIODS”; or
	“CAUTION—THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED. PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL”; and
(ii)	in a primary pack containing not more than 12 such powders or sachets of granules
Atropine—
	(a)	in preparations containing 0.25% or less of atropine; or
	(b)	atropine sulphate, 0.6 mg tablets in packs of six, when labelled for treatment of organophosphorus poisoning;
	except atropine methonitrate included in Schedule 4
Belladonna in preparations containing 0.25% or less of the alkaloids of belladonna, calculated as hyoscyamine
Benzamine when included in—
	(a)	lozenges, pastilles, tablets or capsules containing 30 mg or less of benzamine in each;
	(b)	suppositories or bougies containing 200 mg or less of benzamine in each; or
	(c)	preparations for external use, other than eye drops, containing 10% or less of benzamine
Benzocaine when included in—
	(a)	lozenges, pastilles, tablets or capsules containing 30 mg or less of bezocaine in each;
	(b)	suppositories or bougies containing 200 mg or less of benzocaine in each; or
	(c)	preparations for external use, other than eye drops, containing 10% or less of benzocaine
Benzoyl Peroxide in preparations for external human therapeutic use containing 5% or less of benzoyl peroxide
Benzydamine in preparations for topical use containing 3% or less of benzydamine
Bromhexine
Brompheniramine in oral preparations when compounded with one or more of the following medicaments—
	(a)	an antitussive, except codeine or dihydrocodeine;
	(b)	an expectorant; or
	(c)	a sympathomimetic amine;
	except in preparations for the treatment of children under 2 years of age
Buclizine in primary packs of 10 doses or less, for the prevention or treatment of motion sickness
Butylaminobenzoate when included in—
	(a)	lozenges, pastilles, tablets or capsules containing 30 mg or less of butylaminobenzoate in each;
	(b)	suppositories or bougies containing 200 mg or less of butylaminobenzoate in each; or
	(c)	preparations for external use, other than eye drops, containing 10% or less of butylaminobenzoate
Carbaryl in preparations for external human therapeutic use containing 2% or less of carbaryl
Carbenoxolone for topical oral use
Carbetapentane, except in preparations containing 0.5% or less of carbetapentane
Chloroform in preparations for therapeutic use, except—
	(a)	when included in Schedule 4; or
	(b)	in preparations containing 0.5% or less of chloroform
Chlorpheniramine in oral preparations when compounded with one or more of the following medicaments—
	(a)	an antitussive, except codeine or dihydrocodeine;
	(b)	an expectorant; or
	(c)	a sympathomimetic amine;
	except in preparations for the treatment of children under 2 years of age
Cinnamedrine
Clioquinol and other halogenated derivatives of 8-Hydroxyquinoline for external human use
Codeine—
	(a)	when compounded with aspirin, paracetamol or salicylamide or any one of their derivatives, in tablets or capsules each containing 10 mg or less of codeine, and no other analgesic substance, when—
(i)	packed in blister or strip packaging or in containers with child-resistant closures; and
(ii)	in a primary pack containing 25 or less dosage units; or
	(b)	when compounded with one or more other therapeutically active substances—
(i)	in divided preparations containing 10 mg or less of codeine per dosage unit and with a recommended dose not exceeding 15 mg of codeine; or
(ii)	in undivided preparations containing 0.25% or less of codeine and with a recommended dose not exceeding 15 mg of codeine
Creosote derived from wood, for human therapeutic use, except in preparations containing 3% or less of phenols included in Schedule 2
Cyanides—see Hydrocyanic Acid
DDT—see Dicophane
Dexchlorpheniramine in oral preparations when compounded with one or more of the following medicaments:
	(a)	an antitussive, except codeine or dihydrocodeine;
	(b)	an expectorant;
	(c)	a sympathomimetic amine;
	except in preparations for the treatment of children under 2 years of age
Dextromethorphan when compounded with one or more other therapeutically active substances—
	(a)	in divided preparations containing 30 mg or less of dextromethorphan per dosage unit and with a recommended dose not exceeding 30 mg of dextromethorphan; or
	(b)	in undivided preparations containing 0.3% or less of dextromethorphan with a recommended dose not exceeding 30 mg of dextromethorphan
trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate (Sputolysin) in oral preparations for the treatment of animals
Dicophane (DDT) in preparations for human therapeutic use
Dicyclomine in preparations containing 0.1% or less of dicyclomine
Dihydrocodeine when compounded with aspirin and no other therapeutically active substance, in divided preparations containing 5 mg or less of dihydrocodeine per dosage unit and with a recommended dose not exceeding 10 mg of dihydrocodeine when—
	(a)	packed in blister or strip packaging or in containers with child-resistant closures; and
	(b)	in a primary pack containing 25 or less dosage units
Dimenhydrinate in primary packs of 10 doses or less, for the prevention or treatment of motion sickness
Dimethisoquin in preparations for topical use
Diphemanil Methylsulphate in preparations for topical use
Diphenhydramine—
	(a)	in primary packs of 10 doses or less, for the prevention or treatment of motion sickness; or
	(b)	in oral preparations when compounded with one or more of the following medicaments:
  (i)	an antitussive, except codeine or dihydrocodeine;
 (ii)	an expectorant;
(iii)	a sympathomimetic amine;
	except in preparations for the treatment of children under 2 years of age
Diphenylpyraline in oral preparations when compounded with one or more of the following medicaments:
	(a)	an antitussive, except codeine or dihydrocodeine;
	(b)	an expectorant;
	(c)	a sympathomimetic amine;
	except in preparations for the treatment of children under 2 years of age
Doxylamine in oral preparations when compounded with one or more of the following medicaments:
	(a)	an antitussive, except codeine or dihydrocodeine;
	(b)	an expectorant;
	(c)	a sympathomimetic amine;
	except in preparations for the treatment of children under 2 years of age
Ephedrine for internal use, when compounded with one or more other therapeutically active substances in preparations containing 30 mg or less of ephedrine per recommended dose, other than preparations for stimulant, appetite suppression or weight control purposes, except in liquid preparations containing 10 mg or less of ephedrine per recommended dose
Erythrityl Tetranitrate for therapeutic use
Etafedrine
Ether for therapeutic use, except—
	(a)	when included in Schedule 4; or
	(b)	in preparations containing 10% or less of ether
Ethoheptazine in preparations containing 1% or less of ethoheptazine
Ethylmorphine when compounded with one or more other therapeutically active substances—
	(a)	in divided preparations containing 10 mg or less of ethylmorphine per dosage unit and with a recommended dose not exceeding 15 mg of ethylmorphine; or
	(b)	in undivided preparations containing 0.25% or less of ethylmorphine with a recommended dose not exceeding 15 mg of ethylmorphine
Fluorides for human therapeutic use, being—
	(a)	sodium fluoride in preparations for ingestion containing 2.2 mg or less of sodium fluoride per dosage unit, except in preparations for the treatment of children under 2 years of age; or
	(b)	in preparations for topical use, except—
 (i)	when included in Schedule 3;
(ii)	in dentifrices containing 1000 mg/kg or less of fluoride ion; or
(iii)	in other substances containing 15 mg/kg or less of fluoride ion
Gelsemium
Glutaraldehyde for human therapeutic use
Glyceryl Trinitrate for therapeutic use, except when included in Schedule 4
Guaiphenesin—
	(a)	in liquid preparations containing 2% (200 mg/10 ml) or less of guaiphenesin; or
	(b)	in divided preparations containing 120 mg or less of guaiphenesin per dosage unit
Hexachlorophane in preparations for human skin cleansing purposes containing 3% or less of hexachlorophane, except in preparations for use on infants as specified in Schedule 4
Homatropine in preparations containing 0.25% or less of homatropine
Human Chorionic Gonadotrophin or Antibody in pregnancy test kits
Hydrocyanic Acid and Cyanides in preparations for therapeutic use containing the equivalent of 0.15% or less of hydrocyanic acid
Hydroquinone in preparations for human therapeutic or cosmetic use containing 2% or less of hydroquinone, except—
	(a)	monobenzone and other alkyl ethers of hydroquinone included in Schedule 4; or
	(b)	in hair treatment preparations containing 1% or less of hydroquinone
8-Hydroxyquinoline and its non-halogenated derivatives for human therapeutic use, except in preparations for external use containing 1% or less of such substances
Hyoscine—
	(a)	in preparations containing 0.25% or less of hyoscine; or
	(b)	in transdermal applicators containing 2 mg or less of hyoscine;
except hyoscine butylbromide included in Schedule 4
Hyoscyamine in preparations containing 0.25% or less of hyoscyamine
Hyoscyamus in preparations containing 0.25% or less of the alkaloids of hyoscyamus calculated as hyoscyamine
Iodine (excluding its salts, derivatives and iodophors) in preparations for human therapeutic use containing more than 2.5% of available iodine
Iron Compounds for human internal use, except—
	(a)	when included in Schedule 4;
	(b)	in divided preparations containing 5 mg or less of iron per dosage unit; or
	(c)	in liquid oral preparations containing 0.1% or less of iron
Isopropamide in preparations containing 2% or less of isopropamide for dermal use
Isosorbide Dinitrate for therapeutic use
Lignocaine when included in—
	(a)	lozenges, pastilles, tablets or capsules containing 30 mg or less of lignocaine in each;
	(b)	suppositories or bougies containing 200 mg or less of lignocaine in each; or
	(c)	preparations for external use, other than eye drops, containing 10% or less of lignocaine
Lindane in preparations for external human therapeutic use containing 2% or less of lindane
Lobelia—
	(a)	in divided preparations containing 2.5 mg or less of lobeline per dosage unit; or
	(b)	in undivided preparations containing 0.05% or less of lobeline;
	except in preparations for smoking or burning
Lobeline—
	(a)	in divided preparations containing 2.5 mg or less of lobeline per dosage unit; or
	(b)	in undivided preparations containing 0.05% or less of lobeline;
	except in preparations for smoking or burning
Luteinising Hormone Antibodies in human ovulation test kits
Maldison in preparations for external human therapeutic use containing 2% or less of maldison
Mebendazole for human therapeutic use
Mercuric Chloride in preparations containing 0.5% or less of mercuric chloride, except when included in Schedule 7
Mercuric Iodide in preparations for therapeutic use containing 2% or less of mercuric iodide
Mercuric Nitrate in preparations for therapeutic use containing 5% or less of mercuric nitrate
Mercuric Oxide and all oxides of mercury
Mercuric Potassium Iodide in preparations for therapeutic use containing the equivalent of 2% or less of mercuric iodide
Mercury Organic Compounds for topical therapeutic use in preparations containing 0.5% or less of mercury
Methoxamine, except in preparations for external use containing 1% or less of methoxamine
Methoxyphenamine
Methylephedrine
Naphazoline
Niclosamide for human therapeutic use
Nitric Esters of polyhydric alcohols for therapeutic use, except when separately specified in these Schedules
Noscapine
Oxethazaine in preparations for internal use
Oxolamine
Oxymetazoline
Papaverine
Paracetamol, except—
	(a)	when included in Schedule 4;
	(b)	tablets or capsules each containing 500 mg or less of paracetamol as the only therapeutically active constituent when—
(i)	the pack is labelled—
	“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR LONG PERIODS”; or
	“CAUTION—THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED. PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL”;
(ii)	packed in blister or strip packaging or in containers with a child-resistant closure; and
(iii)	in a primary pack containing not more than 25 such tablets or capsules; or
	(c)	in individually wrapped powders or sachets of granules each containing 1000 mg or less of paracetamol as the only therapeutically active constituent when—
(i)	the pack is labelled—
	“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR LONG PERIODS”; or
	“CAUTION—THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED. PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL”; and
(ii)	in a primary pack containing not more than 12 such powders or sachets of granules
Phedrazine
Phenamazoline
Phenazone for external use
Pheniramine—
	(a)	in primary packs of 10 doses or less, for the prevention or treatment of motion sickness; or
	(b)	in oral preparations when compounded with one or more of the following medicaments:
  (i)	an antitussive, except codeine or dihydrocodeine;
 (ii)	an expectorant;
(iii)	a sympathomimetic amine;
	except in preparations for the treatment of children under 2 years of age
Phenol and any homologue of phenol boiling below 220 Degrees C for human therapeutic use, except in preparations containing 3% or less by weight of such substances
Phenylenediamines and alkylated phenylenediamines for therapeutic use
Phenylephrine, except—
	(a)	when included in Schedule 4;
	(b)	preparations containing 0.5% or less of phenylephrine; or
	(c)	preparations for external use containing 1% or less of phenylephrine
Pholcodine when compounded with one or more other therapeutically active substances—
	(a)	in divided preparations containing 10 mg or less of pholcodine per dosage unit and with a recommended dose not exceeding 25 mg of pholcodine; or
	(b)	in undivided preparations containing 0.5% or less of pholcodine and with a recommended dose not exceeding 25 mg of pholcodine
Podophyllotoxin for external human therapeutic use in preparations containing 2% or less of podophyllotoxin
Podophyllum Resin (Podophyllin) for external human therapeutic use in preparations containing 10% or less of podophyllin
Potassium Chlorate for therapeutic use, except in preparations containing 10% or less of potassium chlorate
Pramoxine when included in preparations for external use, other than eye drops, containing 1% or less of pramoxine
Procyclidine in preparations containing 5% or less of procyclidine for dermal use
Promethazine—
	(a)	in primary packs of 10 doses or less, for the prevention or treatment of motion sickness; or
	(b)	in oral preparations when compounded with one or more of the following medicaments:
  (i)	an antitussive, except codeine or dihydrocodeine;
 (ii)	an expectorant;
(iii)	a sympathomimetic amine;
	except in preparations for the treatment of children under 2 years of age
Propantheline in preparations for topical use
Pseudoephedrine—
	(a)	in divided preparations containing 60 mg or less of pseudoephedrine per recommended dose;
	(b)	in other divided preparations containing 120 mg or less of pseudoephedrine per recommended dose in slow release form, for which approval for the slow release characteristic has been granted by the Commonwealth Department of Community Services and Health; or
	(c)	in liquid preparations containing 60 mg or less of pseudoephedrine per recommended dose;
	except when included in Schedule 4
Pyrantel for human therapeutic use
Pyrithione Zinc for human therapeutic use when—
	(a)	in semisolid hair preparations; or
	(b)	in shampoos labelled—
		“KEEP OUT OF EYES”; or
		“IF IN EYES, RINSE WELL WITH WATER”;
	except in preparations containing 2% or less of pyrithione zinc
Salicylamide, except when included in Schedule 4
Silver Salts for therapeutic use, except—
	(a)	chewing tablets containing 5 mg or less	of silver per tablet when the pack is labelled—
		“WARNING—OVERUSE MAY STAIN THE SKIN OR MOUTH”; or
	(b)	solutions containing 0.3% or less of silver when the pack is labelled—
		“WARNING—OVERUSE MAY STAIN THE SKIN OR MOUTH”
Sodium Nitrite for therapeutic use
Sputolysin-see trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate
Staphisagria, except in preparations containing 0.2% or less of staphisagria
Stramonium in preparations containing 0.25% or less of the alkaloids calculated as hyoscyamine, except preparations for smoking or burning
Tetrahydrozoline
Thenyldiamine—
	(a)	in nasal preparations for topical use; or
	(b)	in oral preparations when compounded with one or more of the following medicaments:
  (i)	an antitussive, except codeine or dihydrocodeine;
 (ii)	an expectorant;
(iii)	a sympathomimetic amine;
	except in preparations for the treatment of children under 2 years of age
Tramazoline
Trimeprazine in oral preparations when compounded with one or more of the following medicaments:
	(a)	an antitussive, except codeine or dihydrocodeine;
	(b)	an expectorant;
	(c)	a sympathomimetic amine;
	except in preparations for the treatment of children under 2 years of age
Triprolidine in oral preparations when compounded with one or more of the following medicaments:
	(a)	an antitussive, except codeine or dihydrocodeine;
	(b)	an expectorant;
	(c)	a sympathomimetic amine;
	except in preparations for the treatment of children under 2 years of age
Tymazoline
Xylometazoline

	SCHEDULE 3	Section 3
Acepifylline in liquid oral preparations
Adrenaline in preparations containing 1% or less of adrenaline, except in preparations containing 0.02% or less of adrenaline
Aminophylline in liquid oral preparations
Amyl Nitrite
Azatadine in oral preparations
Benzoyl Peroxide in preparations containing 10% or less of benzoyl peroxide for external human therapeutic use, except when included in Schedule 2
Brompheniramine in oral preparations, except when included in Schedule 2
Buclizine in oral preparations, except when included in Schedule 2
Butyl Nitrite
Chloral Hydrate for human internal therapeutic use in preparations containing 5% or less of chloral hydrate, when packed in containers of 100 ml, or less
Chlorofluorocarbons—see Fluorocarbons
Chlorpheniramine in oral preparations, except when included in Schedule 2
Clemastine in oral preparations
Clotrimazole for human use in preparations containing 1% or less of clotrimazole, for treatment of fungal infections of the skin
Codeine in capsules or tablets each containing 10 mg or less of codeine when compounded with aspirin, paracetamol or salicylamide or any one of their derivatives and no other analgesic substance, except when included in Schedule 2
Cyproheptadine in oral preparations
Dexchlorpheniramine in oral preparations, except when included in Schedule 2
Dihydrocodeine when compounded with one or more other therapeutically active substances—
	(a)	in divided preparations containing 10 mg or less per dosage unit and with a recommended dose not exceeding 15 mg of dihydrocodeine; or
	(b)	in undivided preparations containing 0.25% or less of dihydrocodeine with a recommended dose not exceeding 15 mg of dihydrocodeine;
	except when included in Schedule 2
Dimenhydrinate in oral preparations, except when included in Schedule 2
Dimethindene in oral preparations
Diphenhydramine in oral preparations, except when included in Schedule 2
Diphenylpyraline in oral preparations, except when included in Schedule 2
Dithranol for human therapeutic use
Doxylamine in oral preparations, except when included in Schedule 2
Econazole for human use in preparations containing 1% or less of econazole for treatment of fungal infections of the skin
Ephedrine for internal use, when compounded with one or more other therapeutically active substances, other than preparations for stimulant, appetite suppression or weight control purposes, except—
	(a)	when included in Schedule 2; or
	(b)	in liquid preparations containing 10 mg or less of ephedrine per recommended dose
Fenoterol in metered aerosols delivering 200 micrograms or less of fenoterol per metered dose
Flavoxate
Fluorides in dentifrices containing more than 1000 mg/kg of fluoride ion
Fluorocarbons and Chlorofluorocarbons alone or in combination with other propellants or refrigerants in liquified gas form for therapeutic use
Folic Acid for human therapeutic use, except in preparations containing 500 micrograms or less of folic acid per recommended daily dose
Folinic Acid for human therapeutic use, except in preparations containing 500 micrograms or less of folinic acid per recommended daily dose
Hydrocortisone and Hydrocortisone Acetate as the only therapeutically active substances in preparations for dermal use containing 0.5% or less of hydrocortisone in packs containing 30 grams or less where the labelling warns against contact with the eyes and against use for acne and on children below 2 years of age, use beyond 7 days, and use under occlusive dressings, except on medical advice
Idoxuridine in preparations containing 0.5% or less of idoxuridine for cutaneous use
Insulin
Isoconazole for human use in preparations containing 1% or less of isoconazole, for treatment of fungal infections of the skin
Loperamide in packs of 8 dosage units or less, each dosage unit containing 2 mg or less of loperamide
Mefenamic Acid in packs of 30 or less capsules for treatment of spasmodic dysmenorrhoea
Mepyramine in oral preparations
Methdilazine in oral preparations
Miconazole for human use in preparations containing 2% or less of miconazole for treatment of fungal infections of the skin
Naproxen in packs of 12 or less tablets or capsules for treatment of spasmodic dysmenorrhoea
Nicotine in chewing tablets containing 2 mg or less of nicotine per tablet for use as an aid in withdrawal from tobacco smoking
Nitrofurazone in preparations for dermal use containing 0.2% or less of nitrofurazone
Octyl Nitrite
Pheniramine in oral preparations, except when included in Schedule 2
Phenylpropanolamine in preparations for relief of coughs or colds containing 25 mg or less per dose of phenylpropanolamine
Phenyltoloxamine in oral preparations
Podophyllotoxin for external human therapeutic use in preparations containing 4% or less of podophyllotoxin, except when included in Schedule 2
Podophyllum Resin (Podophyllin) for external human therapeutic use in preparations containing 20% or less of podophyllin, except when included in Schedule 2
Promethazine in oral preparations, except when included in Schedule 2
Pseudoephedrine, except when included in Schedule 2 or 4
Quinine for human internal therapeutic use, except in liquids containing 40 mg/L or less of quinine
Salbutamol—
	(a)	in metered aerosols delivering 100 micrograms or less of salbutamol per metered dose; or
	(b)	in capsules of dry powder for inhalation delivering 200 micrograms or less of salbutamol per dose
Santonin
Sodium Cromoglycate in nasal preparations for topical use
Terbutaline in metered aerosols delivering 250 micrograms or less of terbutaline per metered dose
Thenyldiamine in oral preparations, except when included in Schedule 2
Theophylline in liquid oral preparations
Tioconazole for human use in preparations containing 1% or less of tioconazole for treatment of fungal infections of the skin
Tretinoin for external human therapeutic use
Trimeprazine—
	(a)	in solid oral preparations; or
	(b)	in liquid oral preparations containing 10 mg or less or trimeprazine per 5 ml;
	except when included in Schedule 2
Triprolidine in oral preparations, except when included in Schedule 2

	SCHEDULE 4	Section 3
Acebutolol
Acepifylline, except when included in Schedule 3
Acepromazine
Acetanilide and alkyl acetanilides, for human therapeutic use
Acetazolamide
Acetohexamide
Acetylcholine
Acetylcysteine
Acetyldihydrocodeine when compounded with one or more other medicaments—
	(a)	in divided preparations containing not more than 100 mg of acetyldihydrocodeine per dosage unit; or
	(b)	in undivided preparations with a concentration of not more than 2.5% of acetyldihydrocodeine
Acetylmethyldimethyloximidophenylhydrazine
Actinomycin D (Dactinomycin)
Acyclovir
Adiphenine
Adrenaline, except—
	(a)	when included in Schedule 3; or
	(b)	in preparations containing 0.02% or less of adrenaline
Alcuronium salts
Allopurinol
Alphadolone
Alphaxalone
Alprazolam
Alprenolol
Alprostadil
Amantadine
Ambenonium
Ambucetamide
Ambutonium
Amethocaine
Amikacin
Amiloride
Aminocaproic Acid
Amioglutethimide
Aminometradine
Aminophenazone and derivatives therefrom for the treatment of animals
Aminophylline, except when included in Schedule 3
Aminopterin
4-Aminopyridine
Aminorex
Aminosalicylic Acid
Amiodarone
Amiphenazole
Amisometradine
Amitriptyline
Amodiaquine
Amoxycillin
Amphomycin
Amphotericin
Ampicillin
Amsacrine
Amylobarbitone when packed and labelled for injection
Amylocaine
Anabolic Steroidal Agents, except when separately specified in these Schedules
Angiotensin Amide
Antazoline, except when included in Schedule 2
Antibiotics, except—
	(a)	when separately specified in these Schedules; or
	(b)	nisin
Antihistamines, except—
	(a)	when included in Schedule 2 or 3; or
	(b)	when separately specified in this Schedule
Antimony, organic compounds of, for therapeutic use
Apomorphine
Aprotinin
Arsenic—see Thiacetarsamide
Aspirin when combined with caffeine, paracetamol or salicylamide or any derivative of these substances
Atenolol
Atracurium Besylate
Atropine Methonitrate
Auranofin
Avoparcin, except when packed and labelled for use as an animal feed additive
Azaperone
Azapetine
Azatadine, except when included in Schedule 3
Azlocillin
Aztreonam
Bacampicillin
Bacitracin, except—
	(a)	when included in Schedule 6;
	(b)	in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances; or
	(c)	in milk replacers for calves and starter rations for pigs containing 100 mg/kg or less of antibiotic substances
Baclofen
Bamipine
Barbituric Acid and its derivatives, except—
	(a)	when included or separately specified in Schedule 8; or
	(b)	when separately specified in this Schedule
Beclamide
Bemegride
Benactyzine, and other substances structurally derived from diphenylmethane with ataractic properties, when used for therapeutic purposes
Bendrofluazide
Benorylate
Benserazide
Benzamine, except when included in Schedule 2
Benzhexol
Benzilonium
Benzocaine, except when included in Schedule 2
Benzodiazepine derivatives, except when separately specified in these Schedules
Benzoyl Peroxide in preparations for external human therapeutic use, except when included in Schedule 2 or 3
Benzphetamine and other substances structurally derived from β‑aminopropylbenzene or β-aminoisopropylbenzene by substitution in the side chain or by ring closure therein (or by both such substitution and such closure), except—
	(a)	where separately specified in this or any other Schedule; or
	(b)	ephedrine in preparations exempted from Schedule 2
Benztropine
Benzydamine, except when included in Schedule 2
Benzylpenicillin (including procaine penicillin), except when included in Schedule 6
Betahistine
Bethanechol Chloride
Bethanidine
Bifonazole
Biperiden
Bismuth compounds for human therapeutic or cosmetic use, except—
	(a)	bismuth citrate when incorporated in hair colourant preparations in concentrations of 0.5% or less;
	(b)	bismuth oxychloride in cosmetics; or
	(c)	bismuth formic iodide or bismuth subiodide in dusting powders containing 3% or less of bismuth
Bleomycin
Boron for human therapeutic use—
	(a)	for internal use;
	(b)	in glycerines or honeys of borax or boric acid;
	(c)	in dusting powders for paediatric use; or
	(d)	as a therapeutically active ingredient in other preparations for dermal use except—
 (i)	in antifungal preparations; or
(ii)	in preparations containing 0.1% or less of boron
Bretylium
Bromazepam
Bromides, inorganic, for therapeutic use
Bromocriptine
Bromoform for therapeutic use
Brompheniramine, except when included in Schedule 2 or 3
Bromvaletone
Buclizine, except when included in Schedule 2 or 3
Bufexamac, except in preparations containing 5% or less of bufexamac for external human therapeutic use, including suppositories
Bumetanide
Bupivacaine
Buprenorphine
Buspirone
Busulphan
Butacaine
Butylaminobenzoate, except when included in Schedule 2
Butylchloral Hydrate
Calcitonin
Calcitriol
Calcium Carbimide for therapeutic use
Camphorated Oil excluding admixtures
Camphotamide
Candicidin
Canine Tick Anti-serum
Cantharidin
Capreomycin
Captodiame
Captopril
Capuride
Caramiphen
Carbachol
Carbamazepine
Carbaryl for human therapeutic use, except when included in Schedule 2
Carbazochrome
Carbenicillin
Carbenoxolone, except when included in Schedule 2
Carbidopa
Carbimazole
Carbocromen
Carboplatin
Carbromal
Cardiac Glycosides, except when separately specified in these Schedules
Carindacillin
Carmustine
Carnidazole for the treatment of pigeons
Cathine
Cefaclor
Cefoperazone
Cefotaxime
Cefotetan
Cefoxitin
Ceftazidime
Ceftriaxone
Cephacetrile
Cephadroxil for the treatment of animals
Cephalexin
Cephaloridine
Cephalothin
Cephamandole
Cephapirin
Cephazolin
Cephradine
Chenodeoxycholic Acid
Chloral Formamide
Chloral Hydrate, except—
	(a)	when included in Schedule 3; or
	(b)	in preparations for topical use containing 2% or less of chloral hydrate
α-Chloralose—see Chloralose
Chloralose, except when included in Schedule 6
Chlorambucil
Chloramphenicol
Chlorazanil
Chlorbutol in preparations for human oral use, except in preparations containing 0.5% or less of chlorbutol as a preservative
Chlorcyclizine
Chlordiazepoxide
Chlormerodrin
Chlormethiazole
Chlormezanone
Chloroform for use in anaesthesia
2-(4-Chlorophenyl)-1, 2, 4-triazole [5, 1a]-isoquinoline for the treatment of animals
Chloroquine
Chlorothiazide
Chlorpheniramine, except when included in Schedule 2 or 3
Chlorphentermine
Chlorpromazine
Chlorpropamide
Chlorprothixene
Chlortetracycline, except when included in Schedule 6
Chlorthalidone
Chlorzoxazone
Cholestyramine for human therapeutic use
Chymopapain, injection for human therapeutic use
Ciclacillin
Cilastatin
Cimetidine
Cinchocaine
Cinoxacin
Ciprofloxacin
Cisplatin
Clanobutin in injections for the treatment of animals
Clavulanic Acid
Clemastine, except when included in Schedule 3
Clemizole
Clenbuterol for the treatment of animals
Clidinium
Clindamycin
Clobazam
Clobetasone-17-butyrate
Clofenamide
Clofibrate
Clomiphene
Clomipramine
Clomocycline
Clonazepam
Clonidine
Clopamide
Cloprostenol for the treatment of animals
Clorazepate
Clorexolone
Clorprenaline
Clotrimazole, except when included in Schedule 3 or 6
Cloxacillin
Clozapine
Codeine when compounded with one or more other therapeutically active substances—
	(a)	in divided preparations containing 30 mg or less of codeine per dosage unit; or
	(b)	in undivided preparations containing 1% or less of codeine;
	except when included in Schedule 2 or 3
Colaspase
Colchicine
Colestipol for human therapeutic use
Colistin
Cortisone and steroid suprarenal cortical hormones, except hydrocortisone in Schedule 3
Curare
Cyclandelate
Cyclizine
Cyclofenil
Cyclopenthiazide
Cyclopentolate
Cyclophosphamide
Cyclopropane for therapeutic use
Cycloserine
Cyclosporin
Cyclothiazide
Cycrimine
Cyproheptadine, except when included in Schedule 3
Cyproterone
Cytarabine
Dacarbazine
Danazol
Dantrolene
Dapsone
Daunorubicin
Deanol
Debrisoquine
Demecarium Bromide
Demeclocycline
Desipramine
Desmopressin (DDAVP)
Detomidine for the treatment of animals
Dexchlorpheniramine, except when included in Schedule 2 or 3
Dextromethorphan, except when included in Schedule 2
Dextropropoxyphene—
	(a)	in divided preparations containing 135 mg or less of dextropropoxyphene per dosage unit; or
	(b)	in liquid preparations containing 2.5% or less of dextropropoxyphene
Dextrorphan
Diazepam
Diazoxide
Dibenzepin
trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate (Sputolysin), except when included in Schedule 2
Dichloralphenazone
Dichlorphenamide
Diclofenac
Dicyclomine, except when included in Schedule 2
Diethazine
Diethylcarbamazine for human therapeutic use
Diethylpropion
Difenoxin in preparations containing, per dosage unit, 0.5 mg or less of difenoxin and a quantity of atropine sulphate equivalent to at least 5% of the dose of difenoxin
Diflunisal
Digitalis and its glycosides
Digoxin Antibody
Dihydralazine
Dihydrocodeine when compounded with one or more other medicaments—
	(a)	in divided preparations containing not more than 100 mg of dihydrocodeine per dosage unit; or
	(b)	in undivided preparations with a concentration of not more than 2.5% of dihydrocodeine;
	except when included in Schedule 2 or 3
Dihydrostreptomycin, except when included in Schedule 6
Diisopropylamine Dichloroacetate
Diltiazem
Dimenhydrinate, except when included in Schedule 2 or 3
Dimethindene, except when included in Schedule 3
Dimethisoquin, except when included in Schedule 2
Dimethoxanate
Dimethyl Sulphoxide for therapeutic use, except—
	(a)	when included in Schedule 6; or
	(b)	in invitro test kits
Dimetridazole
Dinitrocresols for therapeutic use
Dinitronaphthols for therapeutic use
Dinitrophenols for therapeutic use
Dinitrothymols for therapeutic use
Dinoprost
Diperodon
Diphemanil Methylsulphate, except when included in Schedule 2
Diphenhydramine, except when included in Schedule 2 or 3
Diphenidol
Diphenoxylate in preparations containing, per dosage unit, 2.5 mg or less of diphenoxylate and a quantity of atropine sulphate equivalent to at least 1% of the dose of diphenoxylate
Diphenylpyraline, except when included in Schedule 2 or 3
Dipivefrin
Dipyridamole
Disophenol
Disopyramide
Distigmine
Disulfiram for therapeutic use
Dithiazanine, except when included in Schedule 6
Dobutamine
Domperidone
Dopamine
Dothiepin
Doxapram
Doxepin
Doxorubicin
Doxycycline
Doxylamine, except when included in Schedule 2 or 3
Droperidol
Drostanolone
Econazole, except when included in Schedule 3 or 6
Edetic Acid for human therapeutic use in preparations for injection or infusion
Emetine, except in preparations containing 0.2% or less of emetine
Enalapril
Enflurane for therapeutic use
Ephedrine except—
	(a)	when included in Schedule 2 or 3;
	(b)	in preparations for topical use containing 1% or less of ephedrine; or
	(c)	when compounded with one or more other therapeutically active substances in liquid preparations for internal use containing 10 mg or less of ephedrine per recommended dose, other than preparations for stimulant, appetite suppression or weight control purposes
Epicillin
Epirubicin
Ergometrine
Ergot
Ergotamine
Erythromycin, except—
	(a)	when included in Schedule 6;
	(b)	in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances; or
	(c)	in milk replacers for calves and starter rations for pigs containing 100 mg/kg or less of antibiotic substances
Estramustine
Ethacrynic Acid
Ethambutol
Ethamivan
Ethchlorvynol
Ether for use in anaesthesia
Ethinamate
Ethoglucid
Ethoheptazine, except when included in Schedule 2
Ethopropazine
Ethosuximide
Ethotoin
Ethoxzolamide
N-Ethylamphetamine
Ethyl Chloride for inhalation anaesthesia
Ethylmorphine when compounded with one or more other medicaments—
	(a)	in divided preparations containing not more than 100 mg of ethylmorphine per dosage unit; or
	(b)	in undivided preparations with a concentration of not more than 2.5% of ethylmorphine;
	except when included in Schedule 2
Ethyloestrenol
Etidocaine
Etidronate, except in tooth pastes and gels containing 1% or less of
etidronate
Etilefrin Hydrochloride
Etoposide
Etretinate
Felypressin
Fencamfamin
Fenfluramine
Fenoprofen
Fenoterol, except when included in Schedule 3
Fenpipramide
Fenpiprane
Fenproporex
Fenprostalene for the treatment of animals
Flavophospholipol, except—
	(a)	when included in Schedule 6; or
	(b)	in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances
Flecainide
Flucloxacillin
Flucytosine
Flufenamic Acid
Flunisolide
Flunitrazepam
Flunixin Meglumine for the treatment of animals
Fluorides in preparations for human ingestion, except when included in Schedule 2 or 3
Fluorouracil
Fluoxymesterone
Fluphenazine
Fluprostenol for the treatment of animals
Flurazepam
Fluroxene for inhalation anaesthesia
Fluspirilene
Follicle Stimulating Hormone-see Gonadotrophins
Framycetin
Frusemide
Fusidic Acid
Galanthamine
Gallamine
Gemeprost
Gentamicin
Glibenclamide
Glibornuride
Gliclazide
Glipizide
Glucagon
Glutethimide
Glyceryl Trinitrate in preparations for injection
Glycopyrrolate
Glymidine
Gonadorelin
Gonadotrophins, except when included in Schedule 2
Gramicidin
Griseofulvin
Growth Hormone
Guaiphenesin, except when included in Schedule 2
Guanabenz
Guanacline
Guanethidine
Halcinonide
Haloperidol and other substances structurally derived from butyrophenone with ataractic properties, when used for therapeutic purposes, except when separately specified in this Schedule
Halothane for therapeutic use
Heparin for internal therapeutic use
Hetacillin
Hexachlorophane—
	(a)	in preparations for use on infants; or
	(b)	in other preparations, except when included in Schedule 2 or 6
Hexamethonium
Hexocyclium
Hyaluronic Acid in preparations for injection
Hydralazine
Hydrochlorothiazide
Hydroflumethiazide
Hydroquinone in preparations for human therapeutic or cosmetic use, except—
	(a)	when included in Schedule 2;
	(b)	alkyl ethers of hydroquinone separately specified in this Schedule; or
	(c)	in hair treatment preparations containing 1% or less of hydroquinone
Hydroxychloroquine
1-Hydroxypyrido (3,2,a)-5-phenoxazone-3-carboxylic Acid
Hydroxyurea
Hydroxyzine
Hygromycin, except—
	(a)	when included in Schedule 6; or
	(b)	in preparations in concentrations of 50 mg/kg or less of antibiotic substances
Hyoscine Butylbromide
Hypothalamic Releasing Factors, except when separately specified in this Schedule
Ibufenac
Ibuprofen
Idoxuridine, except when included in Schedule 3
Imipenem
Imipramine
Indapamide
Indomethacin
Inositol Nicotinate for internal use
Interferon
Ion-exchange Resins, anionic and cationic, for internal use in humans, except when separately specified in this Schedule
Iopamidol
Ipratropium
Iproniazid
Iron compounds in injectable preparations for human therapeutic use
Isoaminile
Isocarboxazid
Isoconazole, except when included in Schedule 3 or 6
Isoetharine
Isoflurane for therapeutic use
Isometheptene
Isoniazid
Isoprenaline
Isopropamide, except when included in Schedule 2
Isotretinoin
Isoxuprine
Kanamycin
Ketamine
Ketoconazole
Ketoprofen
Khellin
Kitasamycin, except—
	(a)	when included in Schedule 6; or
	(b)	in animal feeds for growth promotion containing 100 mg/kg or less of antibiotic substances
Labetalol
Latamoxef
Laudexium Methylsulphate
Lead Compounds for human therapeutic use
Lefetamine
Leptazol
Leuprorelin
Levallorphan
Levamisole—
	(a)	for human therapeutic use; or
	(b)	in preparations for the prevention or treatment of heartworm in dogs
Levodopa
Lidoflazine
Lignocaine, except when included in Schedule 2
Lincomycin
Lindane for human therapeutic use, except when included in Schedule 2
Liothyronine Sodium (Triiodothyronine)
Lithium salts for therapeutic use, except in preparations containing 0.01% or less of lithium
Lomustine
Loperamide, except when included in Schedule 3
Lorazepam
Loxapine
Luteinising Hormone--see Gonadotrophins
Lymecycline
Mafenide, except when included in Schedule 6
Maldison for human therapeutic use, except when included in Schedule 2
Maprotiline
Mazindol
Mebeverine
Mebhydrolin
Mecamylamine
Meclofenoxate
Meclozine
Medazepam
Mefenamic Acid, except when included in Schedule 3
Mefenorex
Mefloquine
Mefruside
Melphalan
Mepacrine
Mepenzolate
Mephenesin and its derivatives, except guaiphenesin where specified in Schedule 2 or 4
Mephentermine
Mepivacaine
Meprobamate
Mepyramine, except when included in Schedule 3
Mercaptopurine
Mercurous Chloride for internal therapeutic use
Mercury (metallic) for therapeutic use
Mercury Organic Compounds for therapeutic use, except when included in Schedule 2
Metaraminol
Metergoline for the treatment of animals
Metformin
Methacycline
Methandienone
Methandriol
Methanthelinium
Methazolamide
Methdilazine, except when included in Schedule 3
Methenolone
Methicillin
Methimazole
Methixene
Methocarbamol
Methoin
Methotrexate
Methoxsalen
Methoxyflurane for therapeutic use
Methsuximide
Methyclothiazide
Methylandrostanolone
Methyldopa
Methylpentynol and other substituted alkynes for internal use
Methyprylone
Methysergide
Metoclopramide
Metolazone
Metoprolol
Metrizamide
Metronidazole including benzoyl metronidazole
Metyrapone
Mexiletine
Mezlocillin
Mianserin
Mibolerone
Miconazole, except when included in Schedule 3 or 6
Midazolam
Minocycline
Minoxidil
Misoprostol
Mithramycin
Mitobronitol
Mitomycin
Mitozantrone
Monensin, except—
	(a)	when included in Schedule 6; or
	(b)	in animal feeds containing 33 mg/kg or less of antibiotic substances
Monobenzone and other alkyl ethers of hydroquinone for human therapeutic or cosmetic use
Monoclonal Antibodies for therapeutic use, except in diagnostic test kits
Moperone
Mupirocin
Mustine
Nadolol
Nalbuphine
Nalidixic Acid, except when included in Schedule 6
Nalorphine
Naloxone
Nandrolone
Naproxen, except when included in Schedule 3
Narasin, except—
	(a)	when included in Schedule 6; or
	(b)	in animal feeds containing 100 mg/kg or less of antibiotic substances
Natamycin
Neomycin, except when included in Schedule 6
Neostigmine
Netilmicin
Nicocodine when compounded with one or more other medicaments—
	(a)	in divided preparations containing not more than 100 mg of nicocodine per dosage unit; or
	(b)	in undivided preparations with a concentration of not more than 2.5% of nicocodine
Nicodicodine when compounded with one or more other medicaments—
	(a)	in divided preparations containing not more than 100 mg of nicodicodine per dosage unit; or
	(b)	in undivided preparations with a concentration of not more than 2.5% of nicodicodine
Nicotine in chewing tablets containing 4 mg or less of nicotine per tablet for use as an aid in withdrawal from tobacco smoking, except when included in Schedule 3
Nicotinic Acid for human therapeutic use, except—
	(a)	in preparations containing 50 mg or less of nicotinic acid per recommended daily dose; or
	(b)	nicotinamide
Nicotinyl Alcohol for internal use
Nicoumalone for internal therapeutic use
Nifedipine
Nifenazone
Nikethamide
Niridazole
Nitrazepam
Nitrofuran and its derivatives for human therapeutic use, except when included in Schedule 3
Nitrous Oxide for therapeutic use
Nomifensine
Noradrenaline, excluding its derivatives
Norcodeine when compounded with one or more other medicaments—
	(a)	in divided preparations containing not more than 100 mg of norcodeine per dosage unit; or
	(b)	in undivided preparations with a concentration of not more than 2.5% of norcodeine
Norethandrolone
Norfloxacin
Nortriptyline
Novobiocin, except when included in Schedule 6
Nystatin
Octamylamine
Octatropine
Oleandomycin, except—
	(a)	when included in Schedule 6; or
	(b)	in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances
Opipramol
Orciprenaline
Organophosphorus Compounds with anticholinesterase activity for human therapeutic use, except—
	(a)	when included in Schedule 2; or
	(b)	when separately specified in this Schedule
Ornidazole
Ornipressin
Orphenadrine
Orthocaine
Orthopterin
Oxacillin
Oxandrolone
Oxazepam
Oxpentifylline
Oxprenolol
Oxybuprocaine
Oxymesterone
Oxymetholone
Oxyphenbutazone
Oxyphencyclimine
Oxyphenonium
Oxytetracycline, except when included in Schedule 6
Oxytocin
Pamaquine
Pancuronium Bromide
Paracetamol when combined with aspirin, caffeine or salicylamide or any derivative of these substances
Paraldehyde
Paromomycin
Pemoline
Pempidine
Penicillamine
Pentamethonium
Penthienate
Pentobarbitone when packed and labelled for injection
Pentolinium
Perhexilene
Pericyazine
Perphenazine
Phenacemide
Phenacetin for therapeutic use
Phenazone, except when included in Schedule 2
Phenazopyridine
Phenelzine
Phenethicillin, except when included in Schedule 6
Phenformin
Phenglutarimide
Phenindione for internal therapeutic use
Pheniramine, except when included in Schedule 2 or 3
Phenoxybenzamine
Phenoxymethylpenicillin, except when included in Schedule 6
Phensuximide
Phentermine
Phenthimentonium
Phentolamine
Phenyapin
Phenylbutazone
Phenylephrine in preparations for human ophthalmic use containing 5% or more of phenylephrine
Phenylpropanolamine, except when included in Schedule 3
Phenyltoloxamine, except when included in Schedule 3
Phenytoin
Pholcodine when compounded with one or more other medicaments—
	(a)	in divided preparations containing not more than 100 mg of pholcodine per dosage unit; or
	(b)	in undivided preparations with a concentration of not more than 2.5% of pholcodine;
	except when included in Schedule 2
Physostigmine
Picrotoxin
Pilocarpine, except in preparations containing 0.025% or less of pilocarpine
Pimozide
Pindolol
Pipenzolate
Piperacillin
Piperidolate
Pipobroman
Pipradrol
Pirenzepine
Piroxicam
Pituitary and its extracts and active principles or their synthetic substitutes, except when separately specified in this Schedule
Pizotifen
Podophyllotoxin for human therapeutic use, except when included in Schedule 2 or 3
Podophyllum Resin (Podophyllin) for human therapeutic use, except when included in Schedule 2 or 3
Polymethylene Bistrimethyl Ammonium Compounds
Polymyxin
Polysulphated Glycosaminoglycans in preparations for injection, except where otherwise specified in this Schedule
Potassium Perchlorate for therapeutic use
Practolol
Pramoxine, except when included in Schedule 2
Prazepam
Prazosin
Pregnenolone Acetate, except in preparations for topical use
Prenylamine
Prilocaine
Primaquine
Primidone
Probenecid
Probucol
Procainamide
Procaine
Procarbazine
Prochlorperazine
Procyclidine, except when included in Schedule 2
Proguanil
Prolintane
Promazine
Promethazine, except when included in Schedule 2 or 3
Propanidid
Propantheline, except when included in Schedule 2
Propofol
Propoxur for human therapeutic use
Propranolol
Propylhexedrine
Propylthiouracil
Propyphenazone
Proquazone
Prostaglandins, except when separately specified in this Schedule
Prostianol for the treatment of animals
Prothionamide
Protirelin (thyrotrophin releasing factor)
Protriptyline
Proxymetacaine
Pseudoephedrine in preparations for stimulant, appetite suppression or weight control purposes
Pyrazinamide
Pyridostigmine
Pyridoxine Hydrochloride in preparations for human use containing more than 50 mg of pyridoxine per recommended daily dose, unless labelled—
	“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG TIME”; or
	“WARNING—THIS PRODUCT CONTAINS PYRIDOXINE HYDROCHLORIDE WHICH MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG TIME”
Pyrimethamine
Pyrovalerone
Quinethazone
Quinidine
Ranitidine
Rauwolfia Serpentina
Ribavirin
Rifampicin
Rimiterol Hydrobromide
Ritodrine
Rolitetracycline
Rosoxacin
Salbutamol, except when included in Schedule 3
Salicylamide when combined with aspirin, caffeine or paracetamol or any derivative of these substances
Salinomycin, except—
	(a)	when included in Schedule 6; or
	(b)	in animal feeds containing 60 mg/kg or less of antibiotic substances
Selenium, except—
	(a)	when included in Schedule 5 or 6;
	(b)	as selenium arsenide in photocopier drums;
	(c)	in animal feeds containing 0.1 g/tonne or less of selenium;
	(d)	in compressed pellets for control of selenium responsive conditions in sheep or cattle; or
	(e)	in fertilizers containing 200 g/tonne or less of selenium
Semisodium Valproate
Sex Hormones and all substances having sex hormonal activity, except when separately specified in these Schedules
Silver Sulphadiazine
Sisomycin
Sodium Cellulose Phosphate for human internal use
Sodium Cromoglycate, except when included in Schedule 3
Sodium Nitroprusside for human therapeutic use
Sodium Pentosan Polysulphate for the treatment of animals
Sodium Valproate
Sontoquine
Sotalol
Sparteine
Spectinomycin
Spiramycin, except—
	(a)	when included in Schedule 6; or
	(b)	in animal feeds for growth promotion in pigs or poultry containing 50 mg/kg or less of antibiotic substances
Spironolactone
Sputolysin—see trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate
Stanolone
Stanozolol
Streptomycin, except when included in Schedule 6
Strophanthus and its glycosides
Strychnine in preparations containing 1.5% or less of strychnine for the treatment of animals
Sulfadoxine
Sulfametrole
Sulindac
Sulphanilamide and its derivatives, except—
	(a)	when included in Schedule 6;
	(b)	when separately specified in this Schedule;
	(c)	oryzalin;
	(d)	sulphaquinoxaline in animals feeds containing 200 mg/kg or less of sulphaquinoxaline; or
	(e)	sulphaquinoxaline when incorporated in baits for the destruction of vermin
Sulphatroxazole for the treatment of animals
Sulphinpyrazone
Sulphomyxin
Sulphonal and alkyl sulphonals
Sulthiame
Suxamethonium Salts
Tacrine
Tamoxifen
Temazepam
Teniposide
Terbutaline, except when included in Schedule 3
Terfenadine
Teropterin
Tetrabenazine
Tetracosactrin
Tetracycline, except when included in Schedule 6
Thalidomide
Thenyldiamine, except when included in Schedule 2 or 3
Theophylline, except when included in Schedule 3
Thiacetarsamide in preparations for the prevention or treatment of heart worm in dogs
Thiacetazone
Thiambutosine
Thiazosulphone
Thiethylperazine
Thioguanine
Thiopropazate
Thioridazine
Thiotepa
Thiothixene
Thiouracil
Thiourea for therapeutic use
Thyroid and its extracts and active principles, except when separately specified in this Schedule
Thyrotrophin (TSH)
Thyroxine Sodium
Tiamulin, except—
	(a)	when included in Schedule 6; or
	(b)	in prepared animal feeds
Ticarcillin
Tiemonium
Tigloidine
Tiletamine for the treatment of animals
Timolol
Tinidazole
Tioconazole, except when included in Schedule 3
Tipepidine
Tobramycin
Tocainide
Tolazamide
Tolazoline for internal use
Tolbutamide
Tolpropamine
Tranexamic Acid
Tranylcypromine
Tretamine
Triamterene
Triaziquone
Triazolam
Trichloroethylene for therapeutic use
Triclofos
Tricyclamol
Tridihexethyl
Trifluoperazine
Trifluperidol
Trimeprazine, except when included in Schedule 2 or 3
Trimetaphan
Trimethoprim
Trimipramine
Trimustine
Trioxysalen
Tripelennamine
Triprolidine, except when included in Schedule 2 or 3
Tropicamide
Troxidone
Tubocurarine
Tylosin, except—
	(a)	when included in Schedule 6;
	(b)	in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances; or
	(c)	in milk replacers for calves or starter rations for pigs containing 100 mg/kg or less of antibiotic substances
Urethane, excluding its derivatives, for therapeutic use
Vaccines, sera, toxoids and antigens, for human parenteral use
Vaccines, veterinary live virus, except—
	(a)	poultry vaccines;
	(b)	pigeon pox vaccine; or
	(c)	scabby mouth vaccine
Valnoctamide
Vancomycin
Vasopressin
Vecuronium Bromide
Verapamil
Veratrum for therapeutic use
Vidarabine
Vinblastine
Vinca Alkaloids, except when separately specified in this Schedule
Vincristine
Vindesine
Viprynium
Virginiamycin, except—
	(a)	when included in Schedule 6; or
	(b)	in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances
Visnadine
Vitamin A for human therapeutic use, except in preparations containing 10 000 I.U. or less of vitamin A per recommended daily dosage
Vitamin D for human therapeutic use, except in preparations containing 25 micrograms or less of vitamin D per recommended daily dosage
Warfarin for internal therapeutic use
Xanthinol Nicotinate
Xylazine
Yohimbine
Zeranol, except when included in Schedule 6
Zinc Compounds for human internal use, except—
	(a)	in preparations with a recommended daily dose of 50 mg or less, but more than 25 mg, of zinc when the pack is labelled—
		“WARNING — THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR LONG PERIODS”; or
		“WARNING — THIS PRODUCT CONTAINS ZINC WHICH MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG PERIOD”; or
	(b)	in preparations with a recommended daily dose of 25 mg or less of zinc
Zolazepam for the treatment of animals

	SCHEDULE 5	Section 3
Acetic Acid (excluding its salts and derivatives) in preparations containing more than 30% of acetic acid, except—
	(a)	when included in Schedule 2 or 6; or
	(b)	for therapeutic use
Acetic Anhydride (excluding its salts and derivatives) in preparations containing more than 30% of acetic anhydride, except—
	(a)	when included in Schedule 6; or
	(b)	for therapeutic use
Acetone, except—
	(a)	in preparations containing 25% or less of acetone; or
	(b)	in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of acetone
Acetophenone—see Phenyl Methyl Ketone
Aklomide
Alkaline Salts, being the carbonate, orthosilicate, metasilicate or tribasic phosphate salts of sodium or potassium, in any combination, except—
	(a)	in preparations containing 10% or less of combined substances;
	(b)	in solid preparations whose pH in 10 g/L aqueous solution is 11.5 or less; or
	(c)	in liquid preparations having a pH of 11.5 or less
Alloxydim
Alphamethrin—see Cypermethrin
Ametryn
Amines—see Epoxy Resins
Amitrole
Ammonia and Ammonium Hydroxide (excluding their salts and derivatives) in preparations containing 5% or less of free ammonia, except—
	(a)	in preparations for human internal therapeutic use;
	(b)	in preparations for inhalation when absorbed in an inert solid material; or
	(c)	in preparations containing 0.5% or less of free ammonia
Ammonium Thiocyanate, except in preparations containing 10% or less of ammonium thiocyanate
Anhydrides—see Epoxy Resins
Arsenic organic compounds in herbicides or defoliant preparations containing 3% or less of arsenic, except when separately specified in this Schedule
Azamethiphos
Barium Silicofluoride when coated on paper in an amount not exceeding 8 mg per sq. cm.
Bendiocarb in preparations containing 2% or less of bendiocarb
Bentazone
Benzoyl Peroxide, except—
	(a)	when included in Schedule 2, 3 or 4; or
	(b)	in preparations containing 2% or less of benzoyl peroxide
BHC (excluding the γ-isomer) in preparations containing 10% or less of BHC
Bioallethrin (including sinbioallethrin), except in preparations containing 10% or less of bioallethrin
Bioresmethrin, except in preparations containing 10% or less of bioresmethrin
Boric Acid (excluding its salts) and Borax, except—
	(a)	when included in Schedule 4;
	(b)	in preparations, other than insect baits, containing 1% or less of boron; or
	(c)	in hand cleaning preparations
Buthidazole
Butoxycarboxim in solid preparations containing 10% or less of butoxycarboxim
Cadmium Sulphide in preparations containing 2.5% or less of cadmium sulphide for human therapeutic use
Calcium Hypochlorite, except in preparations containing 4% or less of available chlorine
Camphor, except—
	(a)	when included in	Schedule 4; or
	(b)	in preparations containing 10% or less of camphor
Carbaryl—
	(a)	in preparations containing 10% or less of carbaryl, except when included in Schedule 2 or 4; or
	(b)	when impregnated into plastic resin material containing 20% or less of carbaryl
Chlorfenac
Chlorfenson
Chlorinated Lime and preparations containing more than 4% of available chlorine
Chlorinating Compounds, except—
	(a)	when separately specified in these Schedules;
	(b)	in preparations, other than liquid preparations, containing 4% or less of available chlorine; or
	(c)	in liquid preparations containing-
 (i)	2% to 4% of available chlorine which are labelled—“WARNING—ENSURE ADEQUATE VENTILATION WHEN USING. VAPOUR MAY BE HARMFUL”; or
(ii)	less than 2% of available chlorine
Chlornidine
Chlorocresol, except in preparations containing 3% or less of chlorocresol
Chlorpyrifos in preparations containing 5% or less of chlorpyrifos
Chlorsulfuron
Clanobutin for the treatment of animals, except when included in Schedule 4
Climbazole in preparations containing 40% or less of climbazole, except in preparations containing 2% or less of climbazole
Clofentezine
Clopyralid
Copper Sulphate, except—
	(a)	in preparations for internal use; or
	(b)	in other preparations containing 5% or less of copper sulphate
4-CPA
Cuprimyxin for the treatment of animals
Curing Agents—see Epoxy Resins
Cyanatryn
Cyanuric Acid, excluding its salts and derivatives
Cyclohexanone Peroxide
Cycloprothrin, except in preparations containing 10% or less of cycloprothrin
Cyfluthrin—
	(a)	in wettable powders containing 10% or less of cyfluthrin; or
	(b)	in emulsifiable concentrates containing 2% or less of cyfluthrin
Cypermethrin in preparations containing 10% or less of cypermethrin
2,4-D
2,4-DB
DDT in preparations containing 10% or less of DDT, except dicophane when included in Schedule 2
2,4-DES
N,N-Diallyldichloroacetamide, except in preparations containing 10% or less of N,N-diallyldichloroacetamide
Diazinon in dust preparations containing 2% or less of diazinon
Dichlofluanid
Dicamba
Dichlone
Dichloroisocyanurates, except in preparations containing 4% or less of available chlorine
Dichlorophen for the treatment of animals
Dichlorvos—
	(a)	when impregnated in plastic resin strip material containing 20% or less of dichlorvos;
	(b)	in sustained release resin pellets containing 20% or less of dichlorvos for the treatment of animals; or
	(c)	in pressurised spray packs containing 10 grams or less of dichlorvos
Diclobutrazol
Dicloran
Dicofol
Dicophane—see DDT
Diethyltoluamide, except in preparations containing 20% or less of diethyltoluamide which are labelled—
	“WARNING—DO NOT DELIBERATELY SNIFF THIS PRODUCT. SNIFFING MIGHT HARM OR KILL YOU”
Dimethirimol
Dimethylformamide in preparations containing 10% or less of dimethylformamide, except in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of dimethylformamide
Diphenamid
Dodine
DSMA in herbicides or defoliant preparations containing 3% or less of arsenic
Enilconazole
Epoxy Resins in liquid form and all amines and organic anhydrides used as curing agents for epoxy resins
EPTC
Ethephon, excluding its salts and derivatives
Ether in preparations containing more than 10% of ether for use in internal combustion engines
Ethofumesate
Ethoxyquin, except in preparations containing 10% or less of ethoxyquin
Ethylene Glycol when packed and labelled as a boiling point and/or freezing point modifier and containing 10 mg/kg of denatonium benzoate as a bittering agent
Fenarimol
Fenoprop
Fenson
Fenthion in preparations containing 20% or less of fenthion when packed in single-use containers having a capacity of 1.0 ml or less
Flamprop-methyl
Fluchloralin
Flumethrin in oil based preparations containing 1% or less of flumethrin
Fluoride and Silicofluoride Ion in preparations containing 0.5% or less of fluorides and silicofluorides, except—
	(a)	in dentifrices containing 1000 mg/kg or less of fluoride and silicofluoride ion; or
	(b)	in preparations containing 15 mg/kg or less of fluoride and silicofluoride ion
Fluvalinate in aqueous preparations containing 25% or less of fluvalinate
Formic Acid (excluding its salts and derivatives), except in preparations containing 0.5% or less of formic acid
Fospirate when impregnated in plastic resin strip material containing 20% or less of fospirate
Furalaxyl
Glutaraldehyde in preparations containing 5% or less of glutaraldehyde, except when included in Schedule 2
Glyphosate
Hexazinone
Hydramethylnone in solid baits containing 2% or less of hydramethylnone in welded plastic labyrinths
Hydrocarbons in liquid form (including kerosene, mineral turpentine, white petroleum spirit, toluene, xylene and light mineral and paraffin oils (but excluding their derivatives)) distilling under 300ºC, except—
	(a)	toluene and xylene when included in Schedule 6;
	(b)	in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of liquid hydrocarbons;
	(c)	in solid or semi-solid preparations;
	(d)	in preparations containing 25% or less of liquid hydrocarbons;
	(e)	in preparations packed in pressurised spray packs; or
	(f)	in adhesives packed in containers each containing 50 grams or less of adhesive
Hydrochloric Acid (excluding its salts and derivatives) in preparations containing 10% or less of hydrochloric acid (HC1), except—
	(a)	in preparations containing 0.5% or less of hydrochloric acid (HC1); or
	(b)	for therapeutic use
Hydrofluoric Acid and Hydrosilicofluoric Acid (excluding their salts and derivatives) in preparations containing 0.5% or less of hydrofluoric acid or hydrosilicofluoric acid, as the case may be
Hydrogen Peroxide (excluding its salts and derivatives), except in preparations containing 6% (20 vol) or less of hydrogen peroxide
Imazalil
Kerosene—see Hydrocarbons
Lead Compounds in preparations for use as hair cosmetics
Levamisole in preparations containing 15% or less of levamisole for the treatment of animals, except when included in Schedule 4
Lindane in preparations containing 10% or less of lindane, except when included in Schedule 2 or 4
Maldison in preparations containing 10% or less of maldison, except—
	(a)	when included in Schedule 2 or 4; or
	(b)	in dust preparations containing 2% or less of maldison
Mancozeb
Maneb
MCPA
MCPB
Mecoprop
Mepiquat
Metalaxyl
Metaldehyde in preparations containing 2% or less of metaldehyde
Methabenzthiazuron
Methanol (excluding its derivatives) in preparations containing 10% or less of methanol, except—
	(a)	in preparations containing 2% or less of methanol; or
	(b)	in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of methanol
Methazole
Methiocarb in pelleted preparations containing 2% or less of methiocarb
Methoxychlor
Methylated Spirits, being Methylated spirit, industrial, as defined by the Spirits Act 1906 (excluding its preparations and admixtures), except in containers having a capacity of more than 5 litres
Methylene Chloride—
	(a)	in pressurised spray packs in preparations that contain more than 10% of methylene chloride, when packed and labelled as degreasers, decarbonisers or paint strippers; and
	(b)	when not in pressurised spray packs
Methyl Ethyl Ketone, except—
	(a)	in preparations containing 25% or less of methyl ethyl ketone; or
	(b)	in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of methyl ethyl ketone
Methyl Ethyl Ketone Peroxide
Methyl Iso-amyl Ketone, except—
	(a)	in preparations containing 25% or less of methyl iso-amyl ketone; or
	(b)	in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of methyl iso-amyl ketone
Methyl Iso-butyl Ketone, except—
	(a)	in preparations containing 25% or less of methyl iso-butyl ketone; or
	(b)	in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of methyl iso-butyl ketone
Methyl Salicylate in liquid preparations containing 25% or more of methyl salicylate, except when included in Schedule 6
N-(3-Methyl-4-thiazolin-2-ylidene)-2,4-xylidene (Cymiazole)
Metiram
Metolachlor
Metribuzin
Mezineb
Mineral Turpentine—see Hydrocarbons
MSMA in herbicides or defoliant preparations containing 3% or less of arsenic
Myclobutanil
NAA, except in preparations containing 25% or less of NAA
Naled when impregnated in plastic resin strip material containing 20% or less of naled
Naphthalene as such
Naphthaleneacetic Acid—see NAA
Naptalam
Nitric Acid (excluding its salts and derivatives) in preparations containing 10% or less of nitric acid, except preparations containing 0.5% or less of nitric acid
Norbormide
Ofurace
Organo-tin Compounds—see Tin Organic Compounds
Oxadixyl
Oxycarboxin
Oxythioquinox
Paclobutrazol
Paradichlorobenzene
Pebulate
Penconazole
Pendimethalin
Peracetic Acid in concentrations of 10% or less or peracetic acid
Petrol, except—
	(a)	in preparations containing 25% or less of petrol; or
	(b)	in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of petrol
Phenisopham
Phenyl Methyl Ketone, except—
	(a)	in preparations containing 25% or less of phenyl methyl ketone; or
	(b)	in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of phenyl methyl ketone
ortho-Phenylphenol, except in preparations containing 5% or less of ortho-phenylphenol
Phosphonic Acid, except in preparations containing 10% or less of phosphonic acid
Phosphoric Acid (excluding its salts and derivatives), except—
	(a)	when packed in containers having a capacity of not less than 10 litres and labelled “CORROSIVE” in bold face sanserif capital letters of a height of not less than 1 cm;
	(b)	in preparations containing 350 g/litre or less of phosphoric acid;
	(c)	in solid and semi-solid preparations; or
	(d)	in professional dental kits
Pirimicarb in preparations containing 0.5% or less of pirimicarb
Poly (Hexamethylene Biguanide), except in preparations containing 5% or less of poly (hexamethylene biguanide)
Potassium Chlorate, except—
	(a)	when included in Schedule 2; or
	(b)	in preparations containing 10% or less of potassium chlorate
Potassium Hydroxide (excluding its salts and derivatives) in preparations containing 5% or less of potassium hydroxide, except in preparations containing 0.5% or less of potassium hydroxide
Potassium Sulphide in preparations for metal treatment in containers each containing 50 g or less of potassium suphide
Prometryn
Propamocarb
Propanil
Propiconazole in preparations containing 20% or less of propiconazole
Propionic Acid (excluding its salts and derivatives) in preparations containing 80% or less of propionic acid, except—
	(a)	in preparations containing 30% or less of propionic acid; or
	(b)	for therapeutic use
Propoxur—
	(a)	in dust preparations containing 3% or less of propoxur;
	(b)	in granular sugar-based fly baits containing 1% or less of propoxur provided the preparation also contains a dark colouring agent and a separate bittering agent;
	(c)	in aerosol packs containing 10 g or less of propoxur; or
	(d)	in printed paper sheets for pest control containing 0.5% or less of propoxur and in any case not more than 100 mg of propoxur per sheet
Pyrethrins, naturally occurring, being pyrethrolone, cinerolone or jasmolone esters of chrysanthemic or pyrethric acids, except in preparations containing 10% or less of such substances
Quaternary Ammonium Compounds in preparations containing more than 10% of quaternary ammonium compounds, except when included in another of these Schedules
Quintozene
Salicylanilide
Selenium Sulphide in preparations containing 2.5% or less of selenium sulphide for topical therapeutic use
Sethoxydim
Sodium Chlorate, except in preparations containing 10% or less of sodium chlorate
Sodium Hydrogen Sulphate, except in preparations containing 10% or less of sodium hydrogen sulphate
Sodium Hydroxide (excluding its salts and derivatives) in preparations containing 5% or less of sodium hydroxide, except in preparations containing 0.5% or less of sodium hydroxide
Sodium Hypochlorite, except in preparations containing 4% or less of available chlorine
Sodium Metabisulphite when packed for domestic use, except in preparations containing 10% or less of sodium metabisulphite
Sodium Nitrite, except—
	(a)	when included in Schedule 2; or
	(b)	in preparations containing 1% or less of sodium nitrite 
Sodium Sulphide—
	(a)	in preparations for metal treatment in containers each containing 50 g or less of sodium sulphide; or
	(b)	in preparations for use as an insect lure
Styrene (excluding its derivatives), except in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of styrene
Sulfometuron-methyl
Sulphamic Acid, except in preparations containing 10% or less of sulphamic acid
2,3,6-TBA
TCA—see Trichloroacetic Acid
TDE in preparations containing 10% or less of TDE
Temephos—
	(a)	in liquid preparations containing 10% or less of temephos; or
	(b)	in powders containing 2% or less of temephos
Terbutryn
Tetrachloroethylene in preparations containing 5% or less of tetrachloroethylene, except—
	(a)	when prepared for therapeutic use;
	(b)	when absorbed into an inert solid; or
	(c)	in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of tetrachloroethylene
Tetrachlorvinphos, except in animal feed containing 0.2% or less of tetrachlorvinphos
Tetramethrin, except in pressurised spray packs
Thiobencarb
Tiocarbazil
Tolclofos-methyl
Tralkoxydim
Triadimefon in wettable powders containing 25% or less of triadimefon
Triadimenol
Tri-allate
Trichloroacetic Acid, alkali salts of
1,1,1-Trichloroethane, except—
	(a)	when included in Schedule 7;
	(b)	in preparations containing 25% or less of 1,1,1-trichloroethane;
	(c)	in packs containing 50 ml or less of 1,1,1-trichloroethane which are labelled—“WARNING—DO NOT DELIBERATELY SNIFF THIS PRODUCT. SNIFFING MIGHT HARM OR KILL YOU”;
	(d)	in aerosols other than for therapeutic use; or
	(e)	in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of 1,1,1-trichloroethane
Trichloroisocyanuric Acid in compressed block form for use in swimming pools or toilet cisterns
Tridiphane
Trietazine
Triflumizole
Turpentine Oil, except—
	(a)	in preparations containing 25% or less of turpentine oil; or
	(b)	in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of turpentine oil
Vernolate
Warfarin in rodent baits containing 0.1% or less of warfarin
Zineb
Ziram

	SCHEDULE 6	Section 3
Acephate
Acetic Acid (excluding its salts and derivatives) in preparations containing more than 80% of acetic acid, except when included in Schedule 2
Acetic Anhydride (excluding its salts and derivatives) in preparations containing more than 80% of acetic anhydride, except for therapeutic use
Acifluorfen
Aldrin
Alphamethrin—see Cypermethrin
Amidithion
2-Amino-butane
Aminocarb in preparations containing 25% or less of aminocarb
Amitraz
Ammonia and Ammonium Hydroxide (excluding their salts and derivatives), except—
	(a)	when included in Schedule 5;
	(b)	in preparations for human internal therapeutic use;
	(c)	in preparations for inhalation when absorbed in an inert solid material; or
	(d)	in preparations containing 0.5% or less of free ammonia
Aniline (excluding its salts and derivatives), except in preparations containing 1% or less of aniline
Arecoline
Arsenic—
	(a)	in ant poisons containing 0.4% or less of arsenic;
	(b)	organic compounds of arsenic in herbicides or defoliant preparations, except when included in Schedule 5;
	(c)	in animal feed premixes containing 4% or less of arsenic;
	(d)	in preparations for the treatment of animals, except thiacetarsamide when included in Schedule 4; or
	(e)	in paints containing more than 0.1% of arsenic when calculated on the basis of the non-volatile content of the paint;
	except when separately specified in this Schedule
Avermectin B1 in preparations containing 1% or less of avermectin B1, for the treatment of animals, when supplied in sealed containers for use in automatic injection equipment
Azaconazole, except in preparations containing 1% or less of azaconazole
Azobenzene
Bacitracin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances
Barium salts, except—
	(a)	when included in Schedule 5;
	(b)	barium sulphate; or
	(c)	barium metaborate in paint
Bendiocarb—
	(a)	in wettable powders containing 80% or less of bendiocarb, when packed in containers or primary packs containing not less than 100g of bendiocarb;
	(b)	in wettable powders containing 20% or less of bendiocarb and not less than 0.002% of denatonium benzoate, when packed in containers or primary packs containing not less than 48 g of bendiocarb and labelled for use as a fly control preparation; or
	(c)	in insoluble granular preparations containing 5% or less of bendiocarb;
	except when included in Schedule 5
Benomyl
Benquinox
Bensulide
5-Benzylfur-3-ylmethyl(1'R,3'S.E)-2',2'-dimethyl-3'-(2-oxo-2,3,4,5-tetrahydro-3- thienylidenemethyl)-cyclopropane Carboxylate
Benzylpenicillin (including procaine penicillin) in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of benzylpenicillin or procaine penicillin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose
Beryllium
BHC (excluding the γ-isomer), except when included in Schedule 5
Bithionol for treatment of animals
Brodifacoum in preparations containing 0.25% or less of brodifacoum
Bromadiolone in preparations containing 0.25% or less of bromadiolone
Bromoform, except when included in Schedule 4
Bromophos
Bromophos-ethyl
Bromoxynil
Brotianide
Bunamidine
Butacarb
Butoxycarboxim, except when included in Schedule 5
2-Butoxy-2'-thiocyano-diethyl Ether
Butynorate
Cacodylic Acid in animal feed premixes containing 4% or less of arsenic
Cadmium compounds, except when included in Schedule 5
Cajuput Oil, except in oils or preparations containing 25% or less of cineole
Calciferol in rodent baits
Cambendazole
Carbaryl, except when included in Schedule 2, 4 or 5
Carbendazim
Carbon Disulphide
α-Chloralose—see Chloralose
Chloralose (α-Chloralose) when packed and labelled for use as a pesticide
Chlordane
Chlorfenethol
Chlormequat
N-[5-Chloro-4-[(4-chlorophenyl)-cyanomethyl]-2-methylphenyl]-2-hydroxy-3,5-diiodobenzamide
Chloroform, except—
	(a)	when included in Schedule 2 or 4; or
	(b)	in preparations containing 10% or less of chloroform
α-Chlorohydrin
Chlorophacinone
Chloropicrin in preparations containing 5% of less of chloropicrin
Chlorothalonil
Chlorpyrifos, except when included in Schedule 5
Chlorpyrifos-methyl
Chlortetracycline in preparations—
	(a)	for topical application to animals for ocular use only; or
	(b)	for intramammary infusion in animals containing not more than 100,000 I.U. per dose of chlortetracycline, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose
Chlorthiamid
Cholecalciferol in rodent baits containing 1 g/kg or less of cholecalciferol
Chromates and Dichromates
Chromium Trioxide, excluding its salts and derivatives
Cineole, except in oils or preparations containing 25% or less of cineole
Climbazole, except—
	(a)	when included in Schedule 5; or
	(b)	in preparations containing 2% or less of climbazole
Clotrimazole for external treatment of animals
Coumaphos in preparations containing 5% or less of coumaphos
Coumatetralyl
Creosote, except—
	(a)	when included in Schedule 2; or
	(b)	in preparations containing 3% or less of phenols and homologues of phenol boiling below 220ºC
Crotoxyphos
Crufomate
Cyanamide
Cyanazine
Cyfluthrin, except—
	(a)	when included in Schedule 5; or
	(b)	in pressurised spray packs containing 1% or less of cyfluthrin
Cyometrinil
Cypermethrin, except when included in Schedule 5
Cythioate
Dazomet
DDT and its preparations, except—
	(a)	when included in Schedule 5; or
	(b)	dicophane included in Schedule 2
Deltamethrin in aqueous formulation containing 1% or less of deltamethrin, when no other organic solvent, other than a glycol, is present
Demeton-O-methyl in preparations containing 10% or less of demeton-O-methyl, or of demeton-O-methyl and demeton-S-methyl
Demeton-S-methyl in preparations containing 10% or less of demeton-S-methyl, or of demeton-S-methyl and demeton-O-methyl
Diazinon, except when included in Schedule 5
Dichlofenthion
ortho-Dichlorobenzene
Dichloroethyl Ether
1,2-Dichloropropane
Dichlorvos in preparations containing 50% or less of dichlorvos, except when included in Schedule 5
Diclofop-methyl
Dicophane—see DDT
Dieldrin
Diethylene Dioxide
Difenacoum in preparations containing 0.25% or less of difenacoum
Difenzoquat
Dihydrostreptomycin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of dihydrostreptomycin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose
Dimethipin
Dimethoate
1,3-Di(methoxycarbonyl)-1-propen-2-yl-dimethyl Phosphate in preparations containing 25% or less of 1,3-di(methoxycarbonyl)-1-propen-2-yl-dimethyl phosphate
Dimethylformamide, except—
	(a)	when included in Schedule 5; or
	(b)	in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of dimethylformamide
Dimethyl sulphoxide—
	(a)	when not for therapeutic use; or
	(b)	for the treatment of animals—
 (i)	when combined with no other therapeutic substance; or
(ii)	in preparations containing copper salicyclate as the only other therapeutic substance
Dimetilan in preparations containing 25% or less of dimetilan
Dinitrocresols and their homologues, in preparations containing 5% or less of such compounds, except—
	(a)	when included in Schedule 4; or
	(b)	when separately specified in this Schedule
Dinotrophenols and their homologues, in preparations containing 5% or less of such compounds, except—
	(a)	when included in Schedule 4; or
	(b)	when separately specified in this Schedule
Dinocap
Dioxacarb
Diphacinone
Diquat
Disulfiram, except when included in Schedule 4
Disulfoton in granular preparations containing 5% or less of disulfoton
Dithianon
Dithiazanine in preparations containing 2% or less of dithiazanine, for the treatment of animals
Dithiocarbamates when prepared for agricultural, horticultural or pastoral purposes, except—
	(a)	when included in Schedule 5; or
	(b)	when separately specified in this Schedule
Diuredosan
DSMA in herbicides or defoliant preparations, except when included in Schedule 5
Econazole for the external treatment of animals
Endosulfan
Endothal
Erythromycin—
	(a)	in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of erythromycin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose; or
	(b)	in animal feed premixes for growth promotion containing 2% or less of antibiotic substances
Esfenvalerate
Ether, except—
	(a)	when included in Schedule 2, 4 or 5; or
	(b)	in preparations containing 10% or less of ether
Ethiofencarb
Ethoate-methyl
Ethoprophos in granular formulations containing 10% or less of ethoprophos and 2% of linseed oil
Ethyl Bromide
Ethyl-2-[4-(6-chloro-2-quinoxalyloxy)phenoxy] propionate (Quizalofop Ethyl)
Ethylene Chlorohydrin
Ethylene Dichloride
Ethylene Glycol when packed and labelled as a boiling point or freezing point modifier, except when included in Schedule 5
Ethylene Glycol Monoalkyl Ethers and their Acetates, except—
	(a)	in preparations containing 10% or less of such substances; or
	(b)	in containers having a capacity of 25 litres or more which are labelled “POISON”, and with the name and quantity of the ether, the name of the manufacturer or the trade mark and the statement “Avoid contact with skin and eyes and avoid breathing the vapour”
Etridiazole
Etrimfos
Eucalyptus Oil, except in preparations containing 25% or less of eucalyptus oil
Famphur in preparations containing 20% or less of famphur
Fenaminosulf in preparations containing 10% or less of fenaminosulf when labelled and packed as dry seed dressings
Fenamiphos in granular preparations containing 5% or less of fenamiphos
Fenazaflor
Fenbutatin-oxide
Fenchlorphos
Fenitrothion
Fenoxacarim in preparations for the treatment of carpets during manufacture
Fenthion, except when included in Schedule 5
Fenvalerate
Ferbam
Flavophospholipol in animal feed premixes for growth promotion containing 2% or less of antibiotic substances
Fluazifop-butyl
Fluazifop-p-butyl
Flucofuron in preparations for the treatment of carpets during manufacture
Flumethrin, except when included in Schedule 5
Fluorides and Silicofluorides, except—
	(a)	when included in Schedule 2, 3, 4 or 5;
	(b)	in preparations containing 3% or less of sodium fluoride or sodium silicofluoride as preservative;
	(c)	in pesticide preparations containing 3.2% or less of ammonium fluosilicate;
	(d)	in dentifrices containing 1000 mg/kg or less of fluoride ion; or
	(e)	in preparations containing 15 mg/kg or less of fluoride ion
Flupropanate
Flusilazol
Flutriafol, except in fertilizers containing 0.5% or less of flutriafol
Fluvalinate, except when included in Schedule 5
Formaldehyde (excluding its derivatives), except in preparations containing 5% or less of formaldehyde
Formothion
Fospirate, except when included in Schedule 5
Fumagillin
Glutaraldehyde, except when included in Schedule 2 or 5
Guazatine
Haloxon
Haloxyfop
Heptachlor
Hexachlorophane in preparations for the treatment of animals
Hydramethylnone, except when included in Schedule 5
Hydrazine
Hydrochloric Acid (excluding its salts and derivatives), except in preparations containing 10% or less of hydrochloric acid (HC1)
Hydrofluoric Acid and Hydrosilicofluoric Acid (excluding their salts and derivatives) in preparations containing 10% or less of hydrofluoric acid or hydrosilicofluoric acid, as the case may be, except when included in Schedule 5
Hydroquinone, except—
	(a)	when included in Schedule 2 or 4; or
	(b)	in preparations containing 10% or less of hydroquinone
Hydrosilicofluoric Acid—see Hydrofluoric Acid
Hygromycin for use as an anthelmintic in animal feed premixes containing 2% or less of antibiotic substances
Imidocarb
Iodine (excluding its salts, derivatives and iodophors), except—
	(a)	when included in Schedule 2; or
	(b)	in solid or semi-solid preparations containing 2.5% or less of available iodine
Iodophors and cadexomer iodine, except in preparations containing 1.5% or less of available iodine
Ioxynil
Iron Compounds for the treatment of animals, except—
	(a)	in liquid or gel preparations containing 0.1% or less of iron; or
	(b)	in animal feeds and feed premixes
Isoconazole for the external treatment of animals
Isocyanates, free organic, except in paints containing 0.1% or less of free organic isocyanates
Ivermectin in preparations containing 0.8 g/L of ivermectin for the treatment of sheep
Kitasamycin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances
Lasalocid, except in animal feeds containing 100 mg/kg or less of antibiotic substances
Laurylisoqinolinium Bromide
Lead Compounds, except—
	(a)	when included in Schedule 4 or 5;
	(b)	in preparations for cosmetic use containing 100 mg/kg or less of lead; or
	(c)	in pencil cores, finger colours, showcard colours, pastels, crayons, poster paints, poster colours or coloured chalks when these products contain 100 mg/kg or less of lead
Levamisole for the treatment of animals, except—
	(a)	when included in Schedule 4 or 5; or
	(b)	in preparations containing 10 mg or less of levamisole for the treatment of ornamental birds or ornamental fish
Lindane, except when included in Schedule 2, 4 or 5
Maduramicin in animal feed premixes containing 1% or less of antibiotic substances
Mafenide for the treatment of aquarium fish
Maldison, except—
	(a)	when included in Schedule 2, 4 or 5; or
	(b)	in dust preparations containing 2% or less of maldison
Mebendazole for the treatment of animals
Meclofenamic Acid for the treatment of animals
Mefluidide
Melaleuca Oil (Ti-tree Oil), except in oils or preparations containing 25% or less of cineole
Menazon
Mercuric Iodide when prepared for agricultural, horticultural, pastoral or industrial use
Mercuric Thiocyanate when prepared for use for photographic purposes
Mercurous Chloride, except when included in Schedule 4
Mercury (metallic), except—
	(a)	when included in Schedule 4; or
	(b)	in scientific instruments
Mercury organic compounds in preparations for agricultural, horticultural or pastoral use, except ethoxyethylmercuric chloride and ethylmercuric chloride in Schedule 7
Metacresolsulphonic Acid and Formaldehyde Condensation Product for the treatment of animals
Metaldehyde, except when included in Schedule 5
Metham
Methanol (excluding its derivatives), except—
	(a)	when included in Schedule 5; or
	(b)	in preparations containing 2% or less of methanol
Methiocarb, except when included in Schedule 5
Methomyl in fly-baits containing 1% or less of methomyl and not less than 0.002% of denatonium benzoate as a bittering agent
Methyl Chloride
Methylenebisthiocyanate, except in preparations containing 1% or less of methylenebisthiocyanate
Methyl Isothiocyanate
Methyl Salicylate, excluding admixtures
Miconazole for the external treatment of animals
Molinate
Monensin—
	(a)	in animal feed premixes for growth promotion or for coccidiosis prevention containing 12.5% or less of monensin; or
	(b)	in intraruminal implants for cattle each containing 35g or less of monensin
MSMA in herbicides or defoliant preparations, except when included in Schedule 5
Nabam—see Dithiocarbamates
Naled, except when included in Schedule 5
Nalidixic Acid when packed and labelled for the treatment of ornamental fish
Naphthalophos when specifically prepared and packed for use as a sheep drench
Narasin in animal feed premixes containing 120 g/kg or less of narasin
Neomycin in preparations for topical application to animals for ocular use only
Nicotine in preparations containing 3% or less of nicotine, when packed and labelled for the treatment of animals
Nimidane in preparations containing 25% or less of nimidane
Nithiamide, except in preparations containing 20% or less of nithiamide
Nitric Acid (excluding its salts and derivatives), except in preparations containing 10% or less of nitric acid as such
Nitrobenzene, except—
	(a)	in solid or semi-solid polishes;
	(b)	in soaps containing 1% or less of nitrobenzene; or
	(c)	in preparations containing 0.1% or less of nitrobenzene
Nitrophenols, ortho, meta and para
Nitroscanate
Nitroxynil
Novobiocin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of novobiocin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose
Octhilinone—see 2-Octyl-4-isothiazolin-3-one
2-Octyl-4-isothiazolin-3-one
Oestradiol-17-β-
	(a)	in ear implants for growth promotion in bovine cattle; or
	(b)	in combination with progesterone, testosterone or trenbolone in ear implants for growth promotion in bovine cattle
Olaquindox in animal feed premixes for growth promotion
Oleandomycin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances
Omethoate in preparations containing 50% or less of omethoate
Organo-tin Compounds—see Tin Organic Compounds
Oxadiazon
Oxalic Acid, except its derivatives and insoluble salts
Oxantel Embonate for the treatment of animals
Oxfendazole
Oxyclozanide
Oxytetracycline in preparations—
	(a)	for topical application to animals for ocular use only; or
	(b)	for intramammary infusion in animals containing not more than 100 000 I.U. per dose of oxytetracycline, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose
Parbendazole
Pentachlorophenol, except in preparations containing 0.5 % or less of pentachlorophenol
Peracetic Acid, except when included in Schedule 5
Perfluidone
Permanganates
Phenethicillin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of phenethicillin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose
Phenkapton in preparations containing 50% or less of phenkapton
Phenol and any homologue of phenol boiling below 220ºC, except—
	(a)	when included in Schedule 2; or
	(b)	in preparations containing 3% or less by weight of such substances
Phenothiazine (excluding its derivatives), except in preparations containing 10% or less of phenothiazine
Phenoxymethylpenicillin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of phenoxymethylpenicillin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose
Phenylenediamines and alkylated phenylenediamines not elsewhere specified in this Schedule or in Schedule 2—
	(a)	when used in hair dyes;
	(b)	in preparations packed and labelled for photographic purposes; or
	(c)	in preparations packed and labelled for testing water, except diethyl- or dimethyl-para-phenylenediamine in tablets containing 10 mg or less of phenylenediamine in opaque strip packaging labelled—
		“FOR WATER TESTING. DO NOT DISCARD TESTING SOLUTIONS INTO POOL”
Phosalone
Phosmet
Phosphides, Metallic
Phosphorus, Yellow (excluding its salts and derivatives) in preparations containing 0.5% or less of free phosphorus
Phoxim
Picric Acid (excluding its derivatives), except in preparations containing 5% or less of picric acid
Pindone
Piperophos
Pirimicarb, except when included in Schedule 5
Pirimiphas-ethyl
Pirimiphas-methyl
Potassium Bromate, except in preparations containing 0.5% or less of potassium bromate
Potassium Cyanate
Potassium Hydroxide (excluding its salts and derivatives), except—
	(a)	when included in Schedule 5; or
	(b)	in preparations containing 0.5% or less of potassium hydroxide
Prochloraz
Profenofos
Progesterone—
	(a)	in a silicone rubber elastomer when used as a controlled-release implant for synchronisation of oestrus in cattle; or
	(b)	in combination with oestradiol-17-β or trenbolone, in ear implants for growth promotion in bovine cattle
Promacyl
Promecarb in preparations containing 50% or less of promecarb
Propachlor
Propargite
Propetamphos
Propiconazole, except when included in Schedule 5
Propionic Acid (excluding its salts and derivatives), except—
	(a)	when included in Schedule 5;
	(b)	in preparations containing 30% or less of propionic acid; or
	(c)	for therapeutic use
Propoxur, except when included in Schedule 4 or 5
Propylene Oxide in preparations containing 4% or less of propylene oxide
Prothiofos
Pyrazophos
Rafoxanide
Salinomycin in animal feed premixes containing 6% or less of antibiotic substances
Selenium Compounds—
	(a)	in preparations containing 2.5% or less of selenium—
 (i)	when packed and labelled for the blueing of gun barrels; or
(ii)	when packed and labelled for photographic purposes;
	(b)	in coated granules containing 1% or less of selenium for application to pasture;
	(c)	as a drench, injection, paste, stock lick or vaccine containing 0.5% or less of selenium for the treatment of animals;
	(d)	in premixes containing 2% or less of selenium when packed and labelled for incorporation into animal feeds to provide 0.1 g/tonne or less of selenium; or
	(e)	in tablets each weighing 2 grams or more and each containing 30 micrograms or less of selenium for incorporation into animal feeds
Silver Nitrate, except—
	(a)	when included in Schedule 2; or
	(b)	in chewing tablets
Sodium Bromate, except in preparations containing 0.5% or less of sodium bromate
Sodium Hydroxide (excluding its salts and derivatives), except—
	(a)	when included in Schedule 5; or
	(b)	in preparations containing 0.5% or less of sodium hydroxide
Spiramycin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances
Streptomycin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of streptomycin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose
Strychnine in grain baits containing 0.5% or less of strychnine
Sulcofuron in preparations for the treatment of carpets during manufacture
Sulphanilamide and its derivatives when packed and labelled for the treatment of ornamental caged birds or ornamental fish
Sulphaquinoxaline when packed and labelled for use as a coccidiostat in poultry, except preparations containing 200 mg/kg or less of sulphaquinoxaline
Sulphuric Acid (excluding its salts and derivatives), except—
	(a)	in fire extinguishers; or
	(b)	in preparations containing 0.5% or less of sulphuric acid
Sulprophos
2,4,5-T
TCA—see Trichloroacetic Acid
TCMTB (2-[thiocyanomethylthio]benzothiazole)
TDE, except when included in Schedule 5
Temephos, except when included in Schedule 5
Terbuthylazine
Terpenes, Chlorinated
Testosterone—
	(a)	testosterone cypionate, dipropionate, enanthate and propionate in preparations labelled for treatment and prevention of pizzle (sheath) rot in wethers;
	(b)	in preparations labelled for masculinisation of wethers for use as 'teaser rams' to stimulate and detect reproductive activity in ewes;
	(c)	in combination with oestradiol-17-β or trenbolone in ear implants for growth promotion in bovine cattle; or
	(d)	in oil preparations for growth promotion purposes labelled for injection at the base of the ear in sheep
Tetrachloroethylene, except—
	(a)	when included in Schedule 5;
	(b)	in preparations containing 6% or less of tetrachloroethylene when absorbed into an inert solid;
	(c)	when prepared for use for the treatment of humans or for the treatment of animals; or
	(d)	in containers having a capacity of more than 25 litres which are labelled “POISON” and state the proportion of tetrachloroethylene
Tetracycline in preparations—
	(a)	for topical application to animals for ocular use only;
	(b)	for intramammary infusion in animals containing not more than 100 000 I.U. per dose of tetracycline, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose; or
	(c)	when packed and labelled for treatment of ornamental caged birds or ornamental fish only
Tetradifon
2,2',6,6'-Tetraisopropyl-diphenyl-carbodiimide in amitraz formulations containing 2% or less of 2,2',6,6'-tetraisopropyl-1-diphenyl-carbodiimide
Tetramisole in preparations for the treatment of animals
Thiazafluron
Thiodicarb
Thiometon
Thiourea and alkyl thioureas, except for therapeutic use
Thiram
Tiamulin for the treatment of animals—
	(a)	in feed premixes containing 25% or less of tiamulin; or
	(b)	in soluble concentrates containing 45% or less of tiamulin
Tin Organic Compounds, being di-alkyl, tri-alkyl and tri-phenyl tin compounds where the alkyl group is methyl, ethyl, propyl or butyl, except—
	(a)	when separately specified in this Schedule; or
	(b)	in plastics
Ti-tree Oil—see Melaleuca Oil
Toluene (excluding its derivatives), except—
	(a)	in preparations containing 50% or less of toluene or toluene and xylene; or
	(b)	in containers having a capacity of more than 25 litres which are labelled “POISON” and state the proportion of toluene or toluene and xylene
Trenbolone—
	(a)	in ear implants for growth promotion in bovine cattle; or
	(b)	in combination with oestradiol-17-β, progesterone or testosterone in ear implants for growth promotion in bovine cattle
Triadimefon, except—
	(a)	when included in Schedule 5; or
	(b)	in fertilizers containing 5 g/kg or less of triadimefon
S,S,S-Tributylphosphorothioate
Trichlorfon
Trichloroacetic Acid, except when included in Schedule 5
Trichloroethylene, except—
	(a)	when included in Schedule 4; or
	(b)	for other human therapeutic use
Trichlorophenol
Triclopyr
Tridemorph
Triethyl Phosphate
Trifluoromethane Sulphonic Acid
Tylosin in animal feed premixes for growth promotion containing 5% or less of antibiotic substances
Vamidothion
Virginiamycin in animal feed premixes for growth promotion containing 2% or less of antibotic substances
Warfarin, except—
	(a)	when included in Schedule 4 or 5; or
	(b)	for external therapeutic use
Xylene (excluding its derivatives), except—
	(a)	in preparations containing 50% or less of xylene or xylene and toluene; or
	(b)	in containers having a capacity of more than 25 litres which are labelled “POISON” and state the proportion of xylene or xylene and toluene
Zeranol in ear implants for use as a growth promotant in steer cattle
Zinc Chloride, except in preparations containing 5% or less of zinc chloride
Zinc p-Phenolsulphonate, except in preparations containing 5% or less of zinc p-phenolsulphonate
Zinc Sulphate, except—
	(a)	when included in Schedule 4;
	(b)	in preparations for human internal use with a recommended daily dose of 50 mg or less of zinc; or
	(c)	in other preparations containing 5% or less of zinc sulphate

	SCHEDULE 7	Section 3
Acrolein
Acrylonitrile
Alachlor
Aldicarb
Aldoxycarb
Allyl Alcohol
Aminocarb, except when included in Schedule 6
4-Aminopyridine, except when included in Schedule 4
Amiton
ANTU
Aromatic Extract Oils, being aromatic hydrocarbons boiling in whole or in part above 300ºC, except when incorporated into solid polymers of either natural or synthetic origin or in fuel oils
Arprinocid
Arsenic, except—
	(a)	thiacetarsamide when included in Schedule 4;
	(b)	when included in Schedule 5 or 6;
	(c)	selenium arsenide in photocopier drums; or
	(d)	in animal feeds containing 75 g/tonne or less of arsenic
Avermectin B1, except when included in Schedule 6
Azinphos-ethyl
Azinphos-methyl
Azocyclotin
Bendiocarb, except when included in Schedule 5 or 6
Benzene (excluding its derivatives), except—
	(a)	preparations containing 15 ml/L or less of benzene; or
	(b)	petrol containing 50 ml/L or less of benzene
Betahydroxyethylhydrazine
Binapacryl
Bithionol, except when included in Schedule 6
Brodifacoum, except when included in Schedule 6
Bromadiolone, except when included in Schedule 6
Calamus for human therapeutic use
Calciferol for use as a rodenticide, except when included in Schedule 6
Camphechlor
Captafol
Captan
Carbadox
Carbofuran
Carbon Tetrachloride
Carbophenothion
Chlordecone
Chlordimeform
Chlorfenvinphos
Chlorine, excluding its salts and derivatives
Chloromethiuron
5-Chloro-3-methyl-4-nitropyrazole
4-Chloro-o-toluidine
Chloropicrin, except when included in Schedule 6
Chlorthiophos
Cholecalciferol for use as a rodenticide, except when included in Schedule 6
Clioquinol and other halogenated 8-hydroxyquinoline derivatives, for internal human use
Coumaphos, except when included in Schedule 6
Cyanides—see Hydrocyanic Acid
Cyhalothrin
Cyhexatin
Deltamethrin, except when included in Schedule 6
Demeton
Demeton-O-methyl, except when included in Schedule 6
Demeton-S-methyl, except when included in Schedule 6
Dialifos
4,4-Diaminodiphenylmethane
1,2-Dibromo-3-chloropropane
1,3-Dichloropropene
Dichlorvos, except when included in Schedule 5 or 6
Dicrotophos
Dienochlor
Difenacoum, except when included in Schedule 6
Dimefox
1,3-Di(methoxycarbonyl)-1-propen-2-yl-dimethyl Phosphate, except when included in Schedule 6
N,N-Dimethyl-4-(phenylazo)-benzamine
Dimethyl Sulphate
Dimetilan, except when included in Schedule 6
Dinitrocresols, except when included in Schedule 4 or 6
Dinitrophenols, except when included in Schedule 4 or 6
Dinoseb
Disulfoton, except when included in Schedule 6
Endrin
Epichlorohydrin
Etaconazole
Ethion
Ethoprophos, except when included in Schedule 6
Ethoxyethylmercuric Chloride
Ethylene Dibromide
Ethylene Oxide
Ethylmercuric Chloride
Famphur, except when included in Schedule 6
Fenaminosulf, except when included in Schedule 6
Fenamiphos, except when included in Schedule 6
Fenoxacarim, except—
	(a)	when included in Schedule 6; or
	(b)	in treated carpets
Fensulfothion
Fenthion-ethyl
Flucofuron, except—
	(a)	when included in Schedule 6; or
	(b)	in treated carpets
Flucythrinate
Flunixin Meglumine, except when included in Schedule 4
Fluoroacetamide
Fluoroacetic Acid
Folpet
Formetanate
Halofuginone, except in prepared stockfeeds containing 3 g/tonne or less of halofuginone
Halogenated Dibenzodioxins and Dibenzofurans
Hexachlorobenzene
Hydrocyanic Acid and Cyanides, except—
	(a)	when included in Schedule 1 or 2; or
	(b)	ferrocyanides and ferricyanides
Hydrofluoric Acid and Hydrosilicofluoric Acid (excluding their salts and derivatives), except when included in Schedule 5 or 6
Isocarbophos
Isofenphos
Ivermectin, except when included in Schedule 6
Leptophos
Maduramicin, except when included in Schedule 6
Mazidox
Mecarbam
Mercuric Chloride when prepared for use for agricultural, industrial, pastoral or horticultural purposes
Methacrifos
Methamidophos
Methapyrilene
Methidathion
Methomyl, except when included in Schedule 6
Methyl Bromide
Mevinphos
Mipafox
Mirex
Monocrotophos
Naphthalophos, except when included in Schedule 6
Nicotine, except—
	(a)	when included in Schedule 3, 4 or 6; or
	(b)	in tobacco prepared and packed for smoking
Nimidane, except when included in Schedule 6
Nitrofen
Omethoate, except when included in Schedule 6
Oxamyl
Oxyfluorfen
Paraquat
Parathion
Parathion-methyl
Phenkapton, except when included in Schedule 6
Phorate
Phosfolan
Polychlorinated Biphenyls
Promecarb, except when included in Schedule 6
Propylene Oxide, except when included in Schedule 6
Pyrinuron
Schradan
Strychnine, except—
	(a)	Nux vomica included in Schedule 1; or
	(b)	when included in Schedule 4 or 6
Sulcofuron, except—
	(a)	when included in Schedule 6; or
	(b)	in treated carpets
Sulfotep
TEPP
Terbufos
Tetrachloroethane
2,2',6,6'-Tetraisopropyl-diphenyl-carbodiimide, except when included in Schedule 6
Thallium
Thiofanox
ortho-Tolidine
Toxaphene—see Camphechlor
Triamiphos
Triazbutil
1,1,1-Trichloroethane in aerosols for therapeutic use
Trichloroisocyanuric Acid, except—
	(a)when included in Schedule 5; or
	(b)	in preparations containing 4% or less of available chlorine
Vinyl Chloride

	SCHEDULE 8	Section 3
Acetyldihydrocodeine, except when included in Schedule 4
Acetylmethadol
Acetylmorphines
Alfentanil
Allylprodine
Alphacetylmethadol
Alphameprodine
Alphamethadol
Alphaprodine
Amphetamine
Amylobarbitone, except when included in Schedule 4
Anileridine
Benzethidine
Benzylmorphine
Betacetylmethadol
Betameprodine
Betamethadol
Betaprodine
Bezitramide
Butobarbitone
Butorphanol
Clonitazene
Cocaine
Coca Leaf
Codeine, except when included in Schedule 2, 3, or 4
Codeine-N-oxide
Codoxime
Concentrate of Poppy Straw (the material arising when poppy straw has entered into a process for concentration of its alkaloids)
4-Cyano-2-dimethylamino-4, 4-diphenylbutane (Methadone intermediate)
4-Cyano-1-methyl-4-phenylpiperidine (Pethidine intermediate A)
Cyclobarbitone
Dexamphetamine
Dextromoramide
Dextropropoxyphene, except when included in Schedule 4
Diampromide
Diethylthiambutene
Difenoxin, except when included in Schedule 4
Dihydrocodeine, except when included in Schedule 2, 3 or 4
Dihydromorphine
Dimenoxadol
Dimepheptanol
Dimethylthiambutene
Dioxaphetyl Butyrate
Diphenoxylate, except when included in Schedule 4
Dipipanone
Drotebanol
Ecgonine and its esters or derivatives which are convertible to ecgonine and cocaine
Ethylmethylthiambutene
Ethylmorphine, except when included in Schedule 2 or 4
Etonitazene
Etoxeridine
Fenetylline
Fentanyl
Furethidine
Hydrocodone
Hydromorphinol
Hydromorphone
Hydroxypethidine
Isomethadone
Levamphetamine
Levomethamphetamine
Levomethorphan
Levomoramide
Levophenacylmorphan
Levorphanol
Mecloqualone
Metazocine
Methadone
Methamphetamine
Methyldesorphine
Methyldihydromorphine
2-Methyl-3-morpholino-1, 1-diphenylpropane Carboxylic Acid (Moramide intermediate)
Methylphenidate
1-Methyl-4-phenylpiperidine-4-carboxylic Acid (Pethidine intermediate C)
Metopon
Morpheridine
Morphine
Morphine Methobromide
Morphine-N-oxide
Myrophine
Nabilone
Nicocodine, except when included in Schedule 4
Nicodicodine, except when included in Schedule 4
Nicomorphine
Noracymethadol
Norcodeine, except when included in Schedule 4
Norlevorphanol
Normethadone
Normorphine
Norpipanone
Opium in any form, except the alkaloids noscapine and papaverine
Oxycodone
Oxymorphone
Pentazocine
Pentobarbitone, except when included in Schedule 4
Pethidine
Phenadoxone
Phenampromide
Phenazocine
Phenmetrazine
Phenomorphan
Phenoperidine
4-Phenylpiperidine-4-carboxylic Acid Ethyl Ester (Pethidine intermediate B)
Pholcodine, except when included in Schedule 2 or 4
Piminodine
Piritramide
Proheptazine
Properidine
Propiram
Quinalbarbitone
Racemethorphan
Racemoramide
Racemorphan
Secbutobarbitone
Sufentanil
Thebacon
Thebaine
Tilidine
Trimeperidine

	SCHEDULE 12	Section 3
Acetorphine
Acetyl-α-methylfentanyl
Alkoxyamphetamines and bromo-substituted alkoxyamphetamines, except when separately specified in this Schedule
Alkoxyphenethylamines and alkyl-substituted alkoxyphenethylamines, except when separately specified in this Schedule
2-Amino-1-(2,5-dimethoxy-4-methyl) phenylpropane (STP, DOM)
4-Bromo-3,5-dimethoxyamphetamine
4-Bromo-2,5-dimethoxyphenethylamine (BDMPEA)
3-Bromo-4-methoxyamphetamine
4-Bromo-3-methoxyamphetamine
Bufotenine
Cannabis
Cannabis Oil
Cannabis Resin
Cathinone
Desomorphine
N,N-Diethyltryptamine (DET)
2,4-Dimethoxyamphetamine
3,4-Dimethoxyamphetamine
2,-5-Dimethoxy-4-bromoamphetamine (DOB)
3,4-Dimethoxy-5-ethoxyamphetamine
2,5-Dimethoxy-4-ethoxyamphetamine
4,5-Dimethoxy-2-ethoxyamphetamine
2,5-Dimethoxy-4-ethyl-α-methylphenylethylamine (DOET)
2,3-Dimethoxy-4,5-methylenedioxyamphetamine
2,5-Dimethoxy-3,4-methylenedioxyamphetamine
2,5-Dimethoxy-α-methylphenylethylamine (DMA)
3,4-Dimethoxyphenylethylamine
3-(2-Dimethylaminoethyl)-4-hydroxyindole (Psilocine, Psilotsin)
3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (DMHP)
N,N-Dimethyltryptamine (DMT)
4,5-Ethylenedioxy-3-methoxyamphetamine
Eticyclidine (PCE)
Etorphine
Harmaline
Harmine
Heroin
3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (Parahexyl)
β-Hydroxyfentanyl
β-Hydroxy-3-methylfentanyl
Ketobemidone
Lysergic Acid
Lysergide (LSD, LSD-25)
Mescaline—see 3,4,5-Trimethoxyphenethylamine
Methaqualone
2-Methoxy-3,4-methylenedioxyamphetamine
2-Methoxy-4,5-methylenedioxyamphetamine
4-Methoxy-2,3-methylenedioxyamphetamine
5-Methoxy-3,4-methylenedioxy-α-methylphenylethylamine (MMDA)
2-Methoxy-3,4-methylenedioxyphenylethylamine
3-Methoxy-4,5-methylenedioxyphenylethylamine
4-Methoxy-α-methylphenylethylamine (PMA)
4-Methoxyphenylethylamine
3,4-Methylenedioxyamphetamine (MDA)
3,4-Methylenedioxy-N, α-dimethylphenylethylamine (MDMA)
3,4-Methylenedioxy-N-ethylamphetamine (MDE)
α-Methylfentanyl
3-Methylfentanyl
1-Methyl-4-phenyl-4-propionoxypiperidine (MPPP)
α-Methylthiofentanyl
3-Methylthiofentanyl
Muscimol
Para-fluorofentanyl
Phencyclidine (PCP)
1-Phenylethyl-4-phenyl-4-acetoxypiperidine (PEPAP)
Psilocine—see 3-(2-Dimethylaminoethyl)-4-hydroxyindole
Psilocybine
Psilotsin—see 3-(2-Dimethylaminoethyl)-4-hydroxyindole
Rolicyclidine (PHP, PCPY)
Tenocyclidine (TCP)
Tetrahydrocannabinols (THC) and their alkyl homologues, except when separately specified in this Schedule
2,3,4,5-Tetramethoxyamphetamine
Thiofentanyl
2,3,4-Trimethoxyamphetamine
2,3,5-Trimethoxyamphetamine
2,3,6-Trimethoxyamphetamine
2,4,5-Trimethoxyamphetamine
2,4,6-Trimethoxyamphetamine
3,4,5-Trimethoxy-α-methylphenylethylamine (TMA)
3,4,5-Trimethoxyphenethylamine (Mescaline) and other substances structurally derived from methoxy-phenylethylamine, except—
	(a)	methoxyphenamine; or

	(b)	when separately specified in this Schedule
1-(3,4,5-Trimethoxyphenyl)-2-aminobutane
2,4,5-Trimethoxyphenylethylamine

NOTES
1.	Notified in the Commonwealth of Australia Gazette on 20 December 1988.
2.	No. 38, 1978 as amended by Nos. 19 and 56, 1981; No. 47, 1982; No. 67, 1985; Nos. 32 and 76, 1986; No. 29, 1988.